oxazolidin-2-one has been researched along with Gram-Positive Bacterial Infections in 438 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (2.28) | 18.2507 |
2000's | 266 (60.73) | 29.6817 |
2010's | 144 (32.88) | 24.3611 |
2020's | 18 (4.11) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Chen, Y; Lei, CW; Li, TY; Liu, SY; Wang, HN | 1 |
Liu, S; Wang, L; Xu, Q; Yang, Q; Yang, W; Zhang, W; Zhu, Y | 1 |
Biggel, M; Haussmann, A; Nüesch-Inderbinen, M; Stephan, R; Treier, A; Zurfluh, K | 1 |
Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
Amann, LF; Huang, J; Iqbal, K; Rohde, H; Tikiso, T; Wicha, SG; Zeitlinger, M | 1 |
Biggel, M; Nüesch-Inderbinen, M; Stephan, R; Treier, A; Zurfluh, K | 1 |
Brenciani, A; Giovanetti, E; Morroni, G; Schwarz, S | 1 |
Bai, YR; Liu, HM; Shen, DD; Sun, C; Wang, SQ; Yuan, S; Zhang, M; Zhou, L; Zhou, T | 1 |
Du, XD; Hao, W; Huang, Y; Ni, J; Schwarz, S; Shan, X; Tang, B; Xu, C; Yan, XM; Yang, H; Zou, C | 1 |
Aires-de-Sousa, M; Bouvier, M; Freire, S; Grilo, T; Poirel, L; Rodrigues, B; Sordo, M | 1 |
Arias, CA; Murray, BE; Singh, KV | 2 |
Chen, L; Han, D; Hao, J; Tang, Z; Xiong, W; Zeng, Z | 1 |
Leng, B; Lu, C; Wang, J; Xu, P; Zhang, W; Zhang, Y; Zou, D | 1 |
Kalantzi, S; Konsta, E; Loupa, CV; Lykoudi, E; Meimeti, E; Moisoglou, I; Voyatzoglou, ED | 1 |
Almeida, LM; Basílio-Júnior, ID; Bispo, PM; Filsner, PH; Gaca, A; Gilmore, MS; Lebreton, F; Moreno, AM; Saavedra, JT; Silva, RA; Zorzi, FM | 1 |
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
Brenciani, A; Cinthi, M; Coccitto, SN; Di Giannatale, E; Fioriti, S; Giovanetti, E; Mingoia, M; Morroni, G | 1 |
Hoy, SM | 1 |
Bensaci, M; Flanagan, S; Sandison, T | 1 |
Bouza, E; Burillo, A; Muñoz, P | 1 |
Bai, B; Chen, Z; Cheng, H; Deng, M; Deng, Q; Hu, K; Li, D; Li, H; Lin, Z; Liu, X; Pan, W; Yao, W; Yu, Z; Zheng, J | 1 |
Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA; Vargas-Cruz, N | 1 |
Castanheira, M; Deshpande, LM; Flamm, RK; Mendes, RE | 1 |
Cui, L; Ding, L; Ding, X; Li, W; Sun, L; Wang, D; Wu, Y; Zhang, Y; Zhao, Y | 1 |
Bender, JK; Fleige, C; Klare, I; Lange, D; Werner, G | 1 |
Antonelli, A; Brenciani, A; Cucco, L; Fioriti, S; Giovanetti, E; Magistrali, CF; Morelli, A; Morroni, G; Paniccià, M; Pezzotti, G; Rossolini, GM | 1 |
Carvalhaes, CG; Flamm, RK; Mendes, RE; Sader, HS | 1 |
Bensaci, M; Corey, R; De Anda, C; Goering, R; Moran, G; Prokocimer, P; Sandison, T | 1 |
Bender, J; Mischnik, A; Mutters, NT; Werner, G | 1 |
Malli, E; Papagiannitsis, CC; Petinaki, E; Tsilipounidaki, K | 1 |
Chen, YP; Kang, ZZ; Kong, LH; Lei, CW; Wang, HN; Wu, SK | 1 |
Glenschek-Sieberth, M; Li, Y; Liu, J; Lyu, Y; Wang, S; Xue, F; Yang, W; Zhang, J | 1 |
Chen, L; Gao, Y; Huang, J; Wang, L; Wang, M | 1 |
Bouillon, B; Defosse, JM; Helmers, A; Mutschler, M; Probst, C; Sakka, SG; Trojan, S; Wappler, F | 1 |
Jain, S; Tu, EY | 1 |
Coyle, E; Kapadia, M; Prince, RA; Rolston, KV; Tarrand, J | 1 |
Baldelli, S; Cattaneo, D; Clementi, E; Cordier, L; Cozzi, V; Fucile, S; Gulisano, C; Merli, S; Orlando, G; Rizzardini, G | 1 |
Carrer, DP; Giamarellou, H; Pefanis, A; Pontikis, K; Tsaganos, T; Tzepi, IM | 1 |
Aasnaes, B; Aronsen, T; Bjørang, O; Hegstad, K; Skrede, T; Sundsfjord, A; Thilesen, CM | 1 |
Barajas, G; Malczynski, M; McLaughlin, M; Qi, C; Radetski, J; Scheetz, MH; Zembower, T | 1 |
Cao, B; Chen, H; He, W; Liu, Y; Ni, M; Wang, H; Wang, Q; Wang, Z; Wu, W; Xia, F; Zhang, J | 1 |
Abbo, L; Correa, R; Gauthier, TP; Shukla, BS; Smith, L | 1 |
Garza-González, E; González, GM; Llaca-Díaz, J; López-Salas, P; Mendoza-Olazarán, S; Morfin-Otero, R; Rodriguez-Noriega, E; Salcido-Gutierres, L; Tinoco, JC | 1 |
Alonso, JM; Cantón, R; Cuartero, C; López, J; Lozano, S; Quiles-Melero, I; Rodríguez, JD; Ruiz-Garbajosa, P; Sánchez-Díaz, AM | 1 |
Farrell, DJ; Jamieson, FB; Memari, N; Patel, SN; Shahinas, D; Toye, B | 1 |
Arrabal-Martin, M; Arrabal-Polo, MA; Gonzalez-Torres, S; Lahoz-Garcia, C; Pareja-Vilchez, M; Valderrama-Illana, P | 1 |
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
Bo, J; Huang, WR; Jing, Y; Li, HH; Wang, QS; Wang, SH; Zhao, Y | 1 |
Flamm, RK; Hogan, PA; Jones, RN; Mendes, RE; Ross, JE | 1 |
Moellering, RC | 2 |
Cattoir, V; Giard, JC | 1 |
Flamm, RK; Hogan, PA; Jones, RN; Mendes, RE; Streit, JM | 1 |
Alavoine, L; Andremont, A; Bourgeois-Nicolaos, N; Defrance, G; Doucet-Populaire, F; Duval, X; Lefort, A; Massias, L; Mentré, F; Nguyen, TT; Noel, V; Senneville, E | 1 |
Chen, L; Dong, H; Dong, Y; Sun, J; Wang, T; Xie, J; Zhao, Y | 1 |
Childs, LM; Kisgen, JJ; Mansour, H; Unger, NR | 1 |
Gordeev, MF; Yuan, ZY | 1 |
Apostolidou-Kiouti, F; Haidich, AB; Ioannidou, M; Niopas, I; Roilides, E | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
Coyle, E; Nesher, L; Prince, RA; Rolston, K; Shelburne, S; Wang, W | 1 |
Andreacchio, KA; Cárdenas, AM; Edelstein, PH | 1 |
Deshpande, LM; Jones, RN; Mendes, RE | 1 |
Batista, ML; Hart, M; Medell, M | 1 |
Aasnæs, B; Hegstad, K; Hide, R; Longva, JÅ; Lunde, TM; Simonsen, GS | 1 |
García-Ramiro, S; Martínez-Pastor, JC; Mensa, J; Morata, L; Soriano, A; Tornero, E | 1 |
Cojutti, P; Crichiutti, G; Isola, M; Maximova, N; Pea, F | 1 |
Celik, M; Cengiz, AB; Ceyhan, M; Kara, A; Karadag Oncel, E; Ozkaya-Parlakay, A; Ozsurekci, Y | 1 |
Hsu, AJ; Tamma, PD | 1 |
Gallagher, JC; Patel, R | 1 |
Li, M; Li, T; Tian, Y; Wang, B; Zhu, Y; Zou, X | 1 |
Bartizal, KF; Bien, PA; Deane, J; Locke, JB; Sahm, DF; Shaw, KJ; Zuill, DE | 1 |
Hickerson, WL; Hill, DM; Wood, GC | 1 |
Mischnik, A; Mutters, NT; Tacconelli, E; Werner, G | 1 |
Cai, J; Cui, L; Deng, X; Feßler, AT; He, T; Hu, Z; Li, J; Li, Y; Lv, Y; Schwarz, S; Shen, J; Shen, Y; Wang, D; Wang, Y; Wang, Z; Wu, C; Xia, X; Yu, H; Zhang, R; Zhao, Q | 1 |
Mischnik, A; Mutters, NT | 1 |
Bodmann, KF; Mutters, R | 1 |
Ashcraft, DS; Deshpande, LM; Farrell, DJ; Jones, RN; Kahn, HP; Mendes, RE; Pankey, G | 1 |
Cardona, AF; Wilson, SE | 1 |
Douros, A; Grabowski, K; Stahlmann, R | 1 |
Albini, TA; Flynn, HW; Kuriyan, AE; Miller, D; Pathengay, A; Relhan, N | 1 |
Brenciani, A; Giovanetti, E; Manso, E; Mingoia, M; Morroni, G; Varaldo, PE; Vincenzi, C | 1 |
Cai, J; Feßler, AT; He, T; Li, J; Lv, Y; Schwarz, S; Shen, J; Shen, Y; Wang, Y; Wu, C; Zhang, R | 1 |
Phillips, OA; Sharaf, LH | 1 |
Fang, J; Li, JJ; Shang, EN; Tang, L; Wang, SN; Weng, XH | 1 |
Cui, L; Li, Y; Liu, J; Lv, Y; Song, Y; Wang, S; Wang, Y; Xue, F; Yang, W; Zhang, J | 1 |
Cai, J; Chen, S; Fan, R; Gu, D; Li, D; Schwarz, S; Shen, Y; Wang, Y; Zhang, G; Zhang, R | 1 |
Eckburg, PB; Ge, Y; Hafkin, B | 1 |
Jang, GC; Jung, SC; Kang, HY; Kim, SR; Lee, HS; Lee, K; Lim, SK; Moon, DC; Nam, HM; Tamang, MD | 1 |
Berdal, JE; Eskesen, A | 1 |
Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
Falagas, ME; Vardakas, KZ | 1 |
Chong, TW; Evans, HL; Hedrick, TL; McElearney, ST; Pruett, TL; Sawyer, RG; Scheld, WM; Smith, RL; Swenson, BR | 1 |
Adani, GL; Baccarani, U; Della Rocca, G; Furlanut, M; Lugano, M; Pavan, F; Pea, F; Tavio, M; Viale, P | 1 |
Antoniadou, A; Fytrou, H; Galani, I; Galani, L; Giamarellou, H; Sakka, V; Siafakas, N; Souli, M; Tsiodras, S; Zerva, L | 1 |
Buechel, BJ; Herrmann, DJ; Ledeboer, NA; Peppard, WJ; Theesfeld, ML; Weigelt, JA | 1 |
Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH | 1 |
Demiröz, AP; Hatipoğlu, CA; Ipekkan, K; Karakoç, EA; Köktekir, E; Yildiz, E | 1 |
Falagas, ME; Kioumis, I; Vardakas, KZ | 1 |
Besnier, JM; De Cock, E; Dupon, M; Duttagupta, S; Guery, B; Levrat, F; Sorensen, S | 1 |
Christofaki, M; Kofteridis, DP; Malliotakis, P; Maraki, S; Samonis, G | 1 |
Garcia-Diaz, J; Hasbun, R; Islam, T; Mave, V | 1 |
Beltrand, E; Dubreuil, L; Legout, L; Migaud, H; Nguyen, S; Pasquet, A; Senneville, E; Yazdanpanah, Y | 1 |
Jhaveri, R; Lopez Marti, MG | 1 |
Jones, RN; Kohno, S; Ono, Y; Ross, JE; Yanagihara, K | 1 |
Alvarez, F; Cereijo, E; Latorre, MM; Martínez, H; Oltra, R; Rodríguez, O | 1 |
Biancofiore, G; Dal Canto, L; Didoni, G; Doria, R; Filipponi, F; Furneri, G; Gemignani, G; Malacarne, P; Menichetti, F; Mosca, C; Papineschi, F; Passaglia, C; Procaccini, M; Tascini, C; Urbani, L | 1 |
Bertz, H; Huebner, J; Jonas, D; Kern, WV; Theilacker, C | 1 |
Hosseini Doust, R; Mohabati Mobarez, A; Satari, M; Teymornejad, O; Yasliani, S | 1 |
Busselo, MS; Cisterna, R; García-Arias, A; Gómez-Gil, R; Gutiérrez-Altés, A; Mingorance, J; Romero-Gómez, MP; Ubeda, MG | 1 |
Chou, J; Chung, D; Cohen, N; Heller, G; Mihu, CN; Papanicolaou, GA; Seo, SK | 1 |
Alvarez, R; Díaz, V; Fernández de Orueta, L; Ramírez, M | 1 |
Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
Farrell, DJ; Jones, RN; Mendes, RE; Ross, JE | 1 |
Bell, JM; Fumiaki, I; Jones, RN; Kobayashi, I; Ross, JE; Turnidge, JD; Utsuki, U | 1 |
Donabedian, S; Johnson, L; Malik, R; Moore, C; Perri, M; Reyes, K; Zervos, M | 1 |
Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
Devasahayam, G; Hoffman, PS; Scheld, WM | 1 |
Efe, S; Ozakin, C; Sinirtaş, M | 1 |
Dotis, J; Ioannidou, M; Iosifidis, E; Roilides, E | 1 |
Chatzi, F; Chrousos, G; Karamolegou, K; Moschovi, M; Santou, A; Tourkantoni, N; Trimis, G; Tsotra, M | 1 |
Alcalá-Santaella, R; Cuadrado, JM; Gazquez, C; Jover-Diaz, F; Olmedo, N; Talents, A | 1 |
Chiappini, E; Conti, C; de Martino, M; Galli, L | 1 |
Alvarez-Lerma, F | 1 |
Bonet, A; de Batlle, J; de la Torre, M; Motjé, M; Piñeiro, L; Sirvent, JM | 1 |
Choi, SH; Chong, YP; Jang, EY; Jeong, JY; Kim, MN; Kim, SH; Kim, YS; Lee, EJ; Lee, SO; Song, EH; Woo, JH | 1 |
Kocher, S; Müller, W; Resch, B | 1 |
Bohnhorst, B; Hansen, G; Hartmann, C; Hermann, E; Peter, C; Sedlacek, L; Ure, B | 1 |
Ang, JY; Deville, JG; Equils, O; Goldfarb, J; Huang, DB; Kaplan, SL; Salazar, JC | 1 |
Ménager, C; Moulin, F | 1 |
Dandekar, G; Dandekar, T | 1 |
Baddley, JW; Kunz, DF; McKinnell, JA; Moser, SA; Patel, M; Shirley, RM | 1 |
Biedenbach, DJ; Farrell, DJ; Jones, RN; Mendes, RE; Ross, JE | 1 |
Ang, JY; Deville, JG; Equils, O; Huang, DB | 1 |
Andreoli, R; Cademartiri, C; Cremaschi, E; Fiaccadori, E; Maccari, C; Maggiore, U | 1 |
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J | 1 |
Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G | 1 |
Fu, R; Guan, J; Liang, Y; Liu, H; Qu, W; Ruan, EB; Shao, ZH; Song, J; Wang, GJ; Wang, HQ; Wang, XM; Wu, YH; Xing, LM | 1 |
Brielmaier, B; Crank, CW; Patel, GP; Ritchie, DJ; Rose, WE; Scheetz, MH; Segreti, J | 1 |
Álvarez Lerma, F; García Simón, M; González Pérez, MI; Rodriguez Colomo, O; Sirvent, JM | 1 |
An, D; Hong, SB; Jeong, TD; Kim, MN; Lee, MY; Sung, H | 1 |
Juntermanns, B; Kaiser, GM; Mathe, Z; Paul, A; Radunz, S; Saner, FH; Treckmann, J | 1 |
Bongiorni, MG; Di Paolo, A; Doria, R; Fondelli, S; Iapoce, R; Leonildi, A; Menichetti, F; Polidori, M; Soldati, E; Tagliaferri, E; Tascini, C | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Brickner, SJ; Leach, KL; Miller, PF; Noe, MC | 1 |
Elshafi, SS; Khan, FY | 1 |
Anastassiou, ED; Chini, V; Damani, A; Kolonitsiou, F; Petinaki, E; Spiliopoulou, I; Zerva, L | 1 |
Cercenado, E | 1 |
Calabuig, E; Salavert, M | 1 |
Cariou, A; Contou, D; Fichet, J; Grimaldi, D | 1 |
Chmelařová, E; Dowzicky, MJ | 1 |
Garazzino, S; Tovo, PA | 1 |
Gould, FK | 1 |
Dryden, MS | 1 |
Clark, K; Corey, GR; Craft, JC; Das, A; Degenhardt, TP; Fernandes, P; Moriarty, SR; Scott, D; Still, JG | 1 |
Beretz, L; Levêque, D; Montserrat, M; Schneider, F | 1 |
Alvey, C; Choo, HW; Cuozzo, C; Damle, B; Kirby, D; Labadie, RR; Riley, S | 1 |
Chandrasekar, PH; Kosmidis, CI | 1 |
Dong, H; Dong, Y; Lei, J; Li, H; Sun, J; Wang, M; Wang, X; Xing, J; You, H; Zhu, H | 1 |
Bertaina, C; Bosis, S; Bozzola, E; Calitri, C; Castagnola, E; Cellini, M; De Gaudio, M; Esposito, S; Gabiano, C; Galli, L; Garazzino, S; Krzysztofiak, A; Lancella, L; Lipreri, R; Losurdo, G; Mancini, L; Mariotti, I; Plebani, A; Pugni, L; Quondamcarlo, A; Scolfaro, C; Soresina, A; Tovo, PA | 1 |
Cleveland, KO; Gelfand, MS; Holloway, K; King, ST; Koeth, L; Usery, JB | 1 |
Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
Bori, G; Cervera, C; García-Ramiro, S; López, R; Martínez-Pastor, JC; Mensa, J; Soriano, A; Sousa, R | 1 |
Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
Kelesidis, T | 1 |
Dowzicky, MJ | 1 |
Butterfield, JM; Huang, DB; Lawrence, KR; Lodise, TP; Reisman, A; Thompson, CA | 1 |
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
Allen, GP; Bearden, DT; Hartung, DM; McGregor, JC; Taplitz, RA; Tong, T; Traver, R | 1 |
Álvarez-Lerma, F; Gimeno Costa, R; Gracia Arnillas, MP; Insausti Ordeñana, J; López Pueyo, MJ; Olaechea Astigarraga, P; Palomar Martínez, M; Seijas Betolaza, I | 1 |
Dimitroulia, E; Kristo, I; Labrou, M; Makris, D; Ntokou, E; Pournaras, S; Stathopoulos, C; Tsakris, A; Vasdeki, A; Zakynthinos, E | 1 |
Chang, CM; Chou, CH; Ko, WC; Lee, CC; Lee, HC; Lee, NY | 1 |
Bordes, J; Carli, P; Cournac, JM; Gaillard, T; Landais, C | 1 |
Clark, NM; Grim, SA; Janda, WM; Layden, JE; Lee, TA; Santayana, EM | 1 |
Anastassiou, ED; Petinaki, E; Spiliopoulou, I | 1 |
Deng, Y; Fan, H; Kang, M; Xiao, Y; Xie, Y; Zhang, Z | 1 |
Cai, JC; Chen, GX; Hu, YY; Zhang, R; Zhou, HW | 1 |
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
Aktaş, G; Bozdoğan, B; Derbentli, S | 1 |
Afşar, I; Barış, I; Demirci, M; Köksal, V; Sener, AG | 1 |
Hellmann, M; Knoll, BM; Kotton, CN | 1 |
Barbosa, F; Berenguer, N; Espona, M; Ferrández, O; Grau, S; Urbina, O | 1 |
Klare, I; Wendt, C; Werner, G; Witte, W | 1 |
Frasca, KL; Schuster, MG | 1 |
Atalay, S; Ece, G; Köse, I; Köse, S; Maraş, G; Samlıoğlu, P | 1 |
Bommarito, S; Chaudhry, A; Farhat, M; Hayakawa, K; Ho, K; Jagadeesh, KK; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Moshos, JA; Mroue, R; Nanjireddy, P; Obeid, T; Parveen, S; Pogue, JM; Rybak, MJ; Singla, M; Sunkara, B; Vadlamudi, G | 1 |
Anderson, TA; Kiser, TH; Mueller, SW; Neumann, RT | 1 |
Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
Borobia, AM; de Montreuil, C; Frías, J; Gómez-Gil, R; González, D; Gutiérrez, A; Hernández, S; Herrero, A; Moreno, F; Muñoz, R; Ramírez, E; Reutero, Z; Zegarra, C | 1 |
Johnson, AP | 1 |
Ballow, CH; Biedenbach, DJ; Jones, RN; Rossi, F | 1 |
Ampofo, K; Graham, PL; Saiman, L | 1 |
Maseda, E; Royo, C; Uña, R; Ureta, P | 1 |
Gonzales, RD; Pai, MP; Petrolatti, JM; Quinn, JP; Rodvold, KA; Schreckenberger, PC | 1 |
Allerberger, FJ; Asboth, F; Johnson, AP; Kaufmann, ME; Livermore, DM; Stockdale, MV; Tysall, L; Warner, M; Woodford, N | 1 |
Budanov, SV; Smirnova, LB | 1 |
Batts, DH; Birmingham, MC; Flavin, SM; Meagher, AK; Rayner, CR; Schentag, JJ | 1 |
Al-Sweih, N; Chugh, TD; Phillips, OA; Udo, EE | 1 |
Carmona, PM; García, J; Gobernado, M; Monte, E; Romá, E | 1 |
Ballow, CH; Bell, JM; Jones, RN; Turnidge, JD | 1 |
Larive, LL; Nguyen, CM; Rhoney, DH | 1 |
Eliopoulos, GM | 2 |
Pigrau, C | 1 |
Wilson, SE | 1 |
Arya, SC | 1 |
Csapó, Z; Flautner, L; Konkoly, TM; Pulay, I; Tihanyi, T; Zsirka, KA | 1 |
Boo, TW; Hone, R; Sheehan, G; Walsh, M | 1 |
Bruss, J; Fleishaker, D; Hilty, M; Naberhuis-Stehouwer, S; Tregnaghi, M; Wible, K | 1 |
Coque, TM; Novais, C; Peixe, LV; Sousa, JC | 1 |
Birmingham, MC; Forrest, A; Meagher, AK; Noskin, GA; Rayner, CR; Schentag, JJ; Smith, PF | 1 |
Ohno, A; Yamaguchi, K | 1 |
MacGowan, AP | 1 |
Livermore, DM | 2 |
Wilcox, MH | 1 |
Barbachyn, MR; Ford, CW | 1 |
Cammarata, S; Hafkin, B; Isturiz, R; Le, V; Oliphant, TH; Remington, J; Rubinstein, E; Smith, LG; Standiford, HC | 1 |
Goa, KL; Lyseng-Williamson, KA | 1 |
Gold, HS; Inglima, K; Pillai, SK; Press, RA; Rahim, S; Venkataraman, L | 1 |
Enne, V; Jones, RN; Mutnick, AH | 1 |
Lomaestro, BM | 1 |
Bassetti, M; Callan, DA; Dembry, LM; Farrel, PA; Topal, JE | 1 |
Balan, DA; Li, JZ; López, H; Mozaffari, E; Rittenhouse, BE; Tang, T; Vidal, G; Willke, RJ; Zitto, T | 1 |
Sunagawa, M; Ueda, Y | 1 |
Caliendo, AM; Somani, J; Thigpen, MC; Zimmer, SM | 1 |
Scheinfeld, NS; Schweiger, ES; Tischler, HR; Weinberg, JM | 1 |
Adler, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Kaplan, SL; Morfin, MR; Naberhuis-Stehouwer, S; Wu, E; Yogev, R | 1 |
Carnuccio, P; Colizza, S; Cucchiara, G; Rodio, F; Rossi, S | 1 |
Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ | 1 |
Kaplan, SL | 1 |
Hopkins, NK; Jungbluth, GL; Welshman, IR | 1 |
Adler, S; Azimi, PH; Beltran, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Jantausch, BA; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
Adler, S; Bruss, JB; Edge-Padbury, B; Kaplan, SL; Martin, A; Morfin, MR; Naberhuis-Stehouwer, S; Patterson, LE; Yogev, R | 1 |
Bruss, JB; Edge-Padbury, B; Kaplan, SL; Meissner, HC; Morfin, MR; Naberhuis-Stehouwer, S; Townsend, T; Wenman, W | 1 |
Bruss, JB; Edge-Padbury, B; Goldfarb, J; Kaplan, SA; Naberhuis-Stehouwer, S; Saiman, L; Wible, K | 1 |
Carver, PL; DePestel, DD; Peloquin, CA | 1 |
Mankin, AS; Quinn, JP; Ruggero, KA; Schreckenberger, PC; Schroeder, LK | 1 |
El-Khoury, J; Fishman, JA | 1 |
Lindley, DA | 1 |
Johnson, JR | 1 |
Birmingham, MC; Forrest, A; Meagher, AK; Rayner, CR; Schentag, JJ | 1 |
Schwartz, MD; Shaikh, ZH; Shive, DK | 1 |
Ang, JY; Asmar, BI; Lua, JL; Turner, DR | 1 |
Cepeda, JA; Cooper, B; Hails, J; Hayman, S; Jones, K; Kibbler, C; Kwaku, F; Shaw, S; Shulman, R; Singer, M; Taylor, L; Whitehouse, T; Wilson, AP | 1 |
Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 1 |
Dryden, M; Nathwani, D; Wilcox, M | 1 |
Kresken, M | 1 |
Bodmann, KF | 1 |
Afif, C; Escalante, C; Hachem, R; Hanna, H; Kantarjian, H; Raad, I; Rolston, K | 1 |
Baddour, LM; Birmingham, MC; Meagher, AK; Norden, C; Rayner, CR; Schentag, JJ | 1 |
Appelbaum, PC; Bozdogan, B | 1 |
Antelo-Lorenzo, R; Hernández-Quero, J; Martinez, M; Parra-Ruiz, J | 1 |
Baer, MR; Ball, D; Dibo, I; Gold, HS; Hazamy, PA; Hsiao, CB; McCarthy, PL; Pillai, SK; Segal, BH; Slack, JL; Wetzler, M | 1 |
Balan, DA; Li, JZ; Mozaffari, E; Nathwani, D; Rittenhouse, BE; Tang, T; Tavakoli, M; Willke, RJ | 1 |
Broder, KW; Forrest, A; Moise, PA; Schentag, JJ; Schultz, RO | 1 |
Rao, N; Santa, ER; Wagener, MM; Yu, VL; Ziran, BH | 1 |
Halle, E; Klare, I; Padberg, J; Rosseau, S; Werner, G; Witte, W | 1 |
Bergh, K; Bevanger, L; Digranes, A; Gaustad, P; Høiby, EA; Melby, KK; Simonsen, GS | 1 |
Chen, YS; Kim, WJ; Lee, SC | 1 |
Hegde, SS; Judice, JK; Kaniga, K; McCullough, J; Obedencio, G; Pace, J; Reyes, N; Shaw, JP; Skinner, R; Thomas, R; Vanasse, N; Wiens, T | 1 |
Rebenok, ZhA | 1 |
Arbuckle, RB; Chaiban, G; Dvorak, T; Hachem, RY; Hanna, HA; Raad, II; Rice, LB | 1 |
Beltrand, E; Dubreuil, L; Giraud, F; Legout, L; Migaud, H; Mouton, Y; Obert, G; Senneville, E; Valette, M; Yazdanpanah, Y | 1 |
Corti, G; Paradisi, F | 1 |
Osmon, DR; Razonable, RR; Steckelberg, JM | 1 |
Naber, KG; Wagenlehner, FM | 1 |
Johnson, AP; Livermore, DM; Mushtaq, S; Warner, M | 1 |
Bernards, AT; Kuijper, EJ; Schippers, EF | 1 |
Burleson, BS; Dunne, WM; Micek, ST; Ritchie, DJ | 1 |
Garg, G; Thami, GP | 1 |
Della Rocca, G; Furlanut, M; Lugano, M; Pavan, F; Pea, F; Scudeller, L; Viale, P | 1 |
Archuleta, S; Keller, MJ; Murphy, B | 1 |
Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H | 1 |
Gomber, S; Narang, M | 1 |
Tan, TQ | 1 |
Blasco, F; García, MJ; Ramos, A; Valverde, ML | 1 |
Brauers, J; Hafner, D; Kresken, M; Shah, PM | 1 |
Bassetti, D; Bassetti, M; Cruciani, M; Di Biagio, A; Melica, G; Molfetta, L; Pipino, F; Righi, E; Vitale, F | 1 |
Fang, CT; Hsueh, PR; Liao, CH; Teng, LJ; Tseng, SP | 1 |
Segreti, J | 1 |
Coyle, EA; Lewis, RE; Prince, RA; Raad, II; Wiederhold, NP | 1 |
Anderegg, TR; Fritsche, TR; Jones, RN; Ross, JE; Sader, HS | 2 |
Choi, EC; Choi, SH; Jo, YW; Lee, TH; Rhee, JK; Shim, MJ; Yoo, M; Yoon, EJ | 1 |
Booker, BM; Kelchin, P; Ogundele, AB; Smith, PF | 1 |
Abbas, H; Das, SS; Karcher, AM; Wareham, DW | 1 |
Forrest, G; Johnson, J; Mehta, S; Venezia, R | 1 |
Buchler, MW; Feldhues, RA; Fritz, S; Geiss, HK; Hoppe-Tichy, T; Martignoni, ME; Swoboda, S | 1 |
Figgitt, DP; Plosker, GL | 1 |
Chiodo, F; Frank, G; Manfredi, R; Sabbatani, S | 1 |
Jenkins, DR; Lovering, A; Prydal, JI; Watts, A | 1 |
Bocquentin, F; Dupon, M; Dutronc, H; Galpérine, T; Lafarie-Castet, S | 1 |
Bogomolova, NS; Bolshakov, LV; Oreshkina, TD | 1 |
Draghi, DC; Hogan, P; Sahm, DF; Sheehan, DJ | 1 |
Mensa, J; Miró, O; Soriano, A | 1 |
Hsueh, PR; Hwang, JJ; Tsai, IJ; Wang, CY; Wang, YT; Wu, KD; Wu, VC | 1 |
Autenrieth, IB; Bahrs, C; Borgmann, S; Heeg, P; Klare, I; Schulte, B; Strommenger, B; Werner, G | 1 |
Grau, S; Marín-Casino, M; Mateu-de Antonio, J; Salas, E; Soto, J | 1 |
Borgmann, S; Eigner, U; Fahr, AM; Jonas, D; Kettlitz, C; Klare, I; Konstabel, C; Mueller-Bertling, S; Schulte, B; Serr, A; Strommenger, B; Werner, G; Witte, W | 1 |
Blais, J; Gao, H; Gómez, M; Gordeev, MF; Huband, M; Jaishankar, P; Renslo, AR; Vara Prasad, JV; Venkatachalam, R | 1 |
Athanassopoulos, G; Giamarellou, H; Iliopoulos, D; Pefanis, A; Perrea, D; Sakka, V | 1 |
Hartman, CS; Jaksic, B; Leonard, LB; Martinelli, G; Perez-Oteyza, J; Tack, KJ | 1 |
Heritage, J; Sandoe, JA; West, AP; Wilcox, MH; Wysome, J | 1 |
Bauer, K; Groll, AH; Hoehn, R; Schaefer, V; Schloesser, RL | 1 |
Bhaskarreddy, KM; Das, J; Iqbal, J; Munikumar, M; Murugan, C; Selvakumar, N; Singh, G; Sitaramkumar, M; Sreenivas, K; Takhi, M; Trehan, S | 1 |
Bonora, MG; Fontana, R; Ligozzi, M; Luzzani, A; Solbiati, M; Stepan, E | 1 |
Cattelan, A; Manara, R; Morelli, E; Salin, F; Scarin, M; Sgarabotto, D; Vianello, F | 1 |
Malczynski, M; Obias, A; Qi, C; Scheetz, MH; Warren, JR; Zheng, X | 1 |
Bonora, MG; Catania, MR; Fontana, R; Luzzani, A; Solbiati, M; Stepan, E; Zorzi, A | 1 |
Bishop, E; Charles, PG; Grayson, ML; Howden, BP; Melvani, S | 1 |
Dimoutsos, M; Giannoudis, PV; Harwood, PJ; Shaw, D; Sunderland, G; Talbot, C; Wilcox, MH | 1 |
Edmond, MB; Major, Y; Marra, AR | 1 |
Bae, HG; Kim, MN; Koo Lee, S; Lee, EJ; Sung, H | 1 |
Bellingan, G; Cepeda, JA; Hayman, S; Singer, M; Whitehouse, T; Wilson, AP | 1 |
Falagas, ME; Manta, KG; Ntziora, F; Vardakas, KZ | 1 |
Giian, CF; Lee, SY; Lu, JJ; Peng, MY; Tsai, TN; Wu, CP | 1 |
Huang, J; Malczynski, M; Noskin, GA; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, TR | 1 |
Dobbs, TE; Hoesley, CJ; Moser, SA; Patel, M; Stamm, AM; Waites, KB | 1 |
Klare, I; Konstabel, C; Sahly, H; Seedat, J; Weiler, N; Zick, G | 1 |
Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
Fraile-Malmierca, F; García-Rodríguez, JA; García-Sánchez, JE; Sánchez, M; Sánchez-Gómez, JC; Valverdé-Romero, ED | 1 |
Scheinfeld, N | 1 |
Ching, CK; Fraser, SL; Wortmann, GW | 1 |
Velissariou, IM | 1 |
Baddour, LM; Coutinho, TD; Murray, BE; Singh, KV; Tsigrelis, C | 1 |
Brauers, J; Kresken, M; Menke, A; Morrissey, I; Orland, A; Weiher, H | 1 |
Falagas, ME; Papagelopoulos, PJ; Siempos, II; Vardakas, KZ | 1 |
Hogan, PA; Jones, RN; Sheehan, DJ; Stilwell, MG | 1 |
Abb, J | 1 |
Fritsche, TR; Jones, RN; Ross, JE; Sader, HS | 3 |
Ariza, A; Azmi, S; Zubaidah, AW | 1 |
Levora, J; Teplan, V; Viklický, O | 1 |
Bouza, E; Marín, M; Moreno, M; Muñoz, P; Ramallo, V; Rodríguez-Creixéms, M | 1 |
Jankowski, A; Stefanik, W | 1 |
Andremont, A; Bourgeois-Nicolaos, N; Butel, MJ; Couson, B; Doucet-Populaire, F; Massias, L | 1 |
Amarnath, PV; Chakrabarti, R; Iqbal, J; Kumar, MS; Kumar, NS; Mallik, A; Rajagopalan, R; Sarnaik, H; Sreenivas, K; Takhi, M; Trehan, S | 1 |
Kohno, S; Yanagihara, K | 1 |
Manfredi, R | 1 |
Yamaguchi, T | 1 |
Ptushkin, VV | 1 |
Hamilton, CW; Rao, N | 1 |
Karanika, M; Melekos, MD; Mitsogiannis, IC; Oeconomou, A; Petinaki, E | 1 |
Campodonico, R; Colli, A; Gherli, T | 1 |
da Silva, PS; Monteiro Neto, H; Sejas, LM | 1 |
Fries, BC; Guo, Y; Patel, G; Wiener, M | 1 |
Cheung, KW; Hui, M; Lee, GC; So, RK; You, JH | 1 |
Choi, EC; Kim, H; Kwon, AR; Shim, MJ; Yoon, EJ; Yoon, JM | 1 |
Carson, B; Dick, J; Milstone, AM; Siberry, GK | 1 |
Bains, HS; Feder, RS; Noskin, GA; Weinberg, DV | 1 |
Aguado, JM; Del Castillo, A; Gonzalez, P; Grau, S; Mateu-de Antonio, J | 1 |
Darini, AL; Freitas, C; Gontijo Filho, PP; Moreira, TA; Ribas, RM | 1 |
Jenkins, I | 1 |
Bonora, MG; Fontana, R; Lo Cascio, G; Olioso, D | 1 |
Ashraf, W; Bayston, R; Freeman, BJ; Nuradeen, B | 1 |
Chen, CJ; Chiu, CH; Huang, YC; Lee, ZL; Lin, TY; Yang, WE | 1 |
Pasculle, AW; Paterson, DL; Pogue, JM; Potoski, BA | 1 |
Ha, NJ; Kim, K; Kim, Y; Lee, DK; Park, KS; Yang, JW | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
Linden, PK | 2 |
Falagas, ME; Siempos, II; Vardakas, KZ | 1 |
Erlandson, KM; Iwen, PC; Rupp, ME; Sun, J | 1 |
Atanasova, V; Rosmanova, R; Slavkova, N | 1 |
Aydemir, S; Cilli, F; Pullukcu, H; Sipahi, OR; Tasbakan, M; Turhan, A; Ulusoy, S | 1 |
Broyles, J; Chow, S; Craig, AS; Devasia, RA; Jones, TF; Kainer, MA; Melton, K; Moore, KL; Schaffner, W; Simmons, BP | 1 |
Burkhardt, O; Mertgen, CP; Pletz, MW; Welte, T | 1 |
Aksoy, DY; Unal, S | 1 |
Barbachyn, MR; Brickner, SJ; Hutchinson, DK; Manninen, PR | 1 |
Knechtel, SA; Malczynski, M; Postelnick, MJ; Qi, C; Scheetz, MH | 1 |
Le Moing, V; Makinson, A | 1 |
Dahlke, J; Franke, G; Heisig, P; Horstkotte, MA; Pothmann, W; Rohde, H; Saager, B; Scherpe, S; Sobottka, I; Timmerbeil, BS | 1 |
Batts, DH; Daley-Yates, PT; Pawsey, SD; Schaadt, RD; Stalker, DJ; Zurenko, GE | 1 |
Andrews, JM; Ashby, JP; Boswell, FJ; Wise, R | 1 |
Kruzynski, J; Noskin, GA; Peterson, LR; Siddiqui, F; Stosor, V | 1 |
Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
Eliopoulos, GM; Moellering, RC; Schülin, T; Thauvin-Eliopoulos, C | 1 |
Abdel-Rahman, SM; Kearns, GL | 1 |
Chien, JW; Kucia, ML; Salata, RA | 1 |
Chandrasekar, PH; Clark, NM; Kauffman, CA; McNeil, SA | 1 |
MacConnachie, AM | 1 |
Lundstrom, TS; Sobel, JD | 1 |
Goldsmith, D; Gransden, W; Melzer, M | 1 |
Batts, DH | 1 |
Plouffe, JF | 1 |
Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY | 1 |
Ballow, CH; Bhavnani, SM | 1 |
Kupecz, D | 1 |
Cinelli, R; Corti, G; Paradisi, F | 1 |
Muller-Serieys, C | 1 |
Müller, M; Schimz, KL | 1 |
Babcock, HM; Christiansen, E; Little, R; Ritchie, DJ; Stanley, S; Starlin, R | 1 |
DenBesten, K; Gonzales, RD; Graham, MB; Kelkar, S; Quinn, JP; Schreckenberger, PC | 1 |
Jarvis, B; Perry, CM | 1 |
Norrby, R | 1 |
Ericsson, CD; Peloquin, CA; Shaikh, ZH | 1 |
Noskin, GA | 1 |
Della-Latta, P; Hammer, SM; Kubin, CJ; Zeana, C | 1 |
Afif, C; Gokaslan, Z; Hachem, R; Raad, I | 1 |
Batts, DH; Eliopoulos, GM; Lavin, BS | 1 |
Bailey, EM; Faber, MD; Nafziger, DA | 1 |
Ho, PL; Ng, TK; Que, TL; Tse, CW; Yip, EK; Yuen, KY; Yung, RW | 1 |
Alvarez-Lerma, F; Grau, S; Luis Gimeno, J; Marín, M | 1 |
Chang, SC; Chen, YC; Fang, CT; Hsieh, SM; Hsieh, WC | 1 |
Jansz, AR; Mouton, JW | 1 |
Marchese, A; Schito, GC | 1 |
Bouza, E; Muñoz, P | 1 |
Antony, SJ; Diaz-Vasquez, E; Stratton, C | 1 |
Gales, AC; Jones, RN; Sader, HS | 1 |
Kuter, DJ; Tillotson, GS | 1 |
Betlejewska, K; Hryniewicz, K; Nowak, K; Szczypa, K | 1 |
Diekema, DJ; Jones, RN | 1 |
Wilson, P | 1 |
Andrefsky, JC; De Georgia, MA; Isada, C; Steinmetz, MP; Vogelbaum, MA | 1 |
Biedenbach, DJ; Della-Latta, P; Jones, RN; Lee, LV | 1 |
Bowker, KE; Holt, HA; MacGowan, AP; Wootton, M | 1 |
Ament, PW; Horne, JP; Jamshed, N | 1 |
Herrero, IA; Issa, NC; Patel, R | 1 |
McAuley, L | 1 |
Balan, D; Li, Z; Nathwani, D; Rittenhouse, B; Vinken, A; Wilike, R | 1 |
Rybak, MJ | 1 |
Johnson, AP; Livermore, DM; Tillotson, GS | 1 |
Nathwani, D | 1 |
Krueger, WA; Unertl, KE | 1 |
Pertel, PE; Till, M; Wixson, RL | 1 |
Hedström, SA | 1 |
Critchley, IA; Jones, ME; Karlowsky, JA; Kelly, LJ; Sahm, DF; Thornsberry, C | 1 |
Rehm, SJ | 1 |
113 review(s) available for oxazolidin-2-one and Gram-Positive Bacterial Infections
Article | Year |
---|---|
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; DNA, Ribosomal; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Interspersed Repetitive Sequences; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Peptidyl Transferases; Ribosomal Proteins | 2022 |
Oxazolidinone: A promising scaffold for the development of antibacterial drugs.
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Structure-Activity Relationship | 2023 |
Contezolid: First Approval.
Topics: Anti-Bacterial Agents; China; Drug Approval; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pyridones; Vancomycin Resistance | 2021 |
The role of tedizolid in skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Tetrazoles; Treatment Outcome | 2018 |
[Enterococci With Special Resistance Patterns - Epidemiology, Hygiene and Therapy].
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Oxazolidinones; Tetrazoles; Tigecycline; Vancomycin Resistance | 2019 |
Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin Resistance | 2013 |
Tedizolid: a novel oxazolidinone for Gram-positive infections.
Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Organophosphates; Oxazoles; Oxazolidinones | 2014 |
Antibiotic resistance in Enterococcus faecium clinical isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Fluoroquinolones; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Penicillins | 2014 |
Tedizolid: a new oxazolidinone antimicrobial.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Tetrazoles | 2014 |
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone Marrow Cells; Clinical Trials, Phase I as Topic; Drug Design; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Pyridones; Sepsis | 2014 |
Efficacy and safety of linezolid for the treatment of infections in children: a meta-analysis.
Topics: Acetamides; Anti-Infective Agents; Child; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Treatment Outcome | 2014 |
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Drug Approval; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Ribosomal Protein L3; Ribosomal Proteins; RNA, Ribosomal, 23S; Tetrazoles | 2014 |
Clinical experience with linezolid for the treatment of orthopaedic implant infections.
Topics: Acetamides; Anemia; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gastroenteritis; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Prosthesis-Related Infections; Treatment Outcome | 2014 |
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2014 |
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
[Treatment options for serious infections caused by vancomycin-resistant enterococci].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterobacteriaceae; Evidence-Based Medicine; Gram-Positive Bacterial Infections; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin-Resistant Enterococci | 2015 |
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Daptomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; North America; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections | 2015 |
Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
Topics: Animals; Anti-Bacterial Agents; Drug Interactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Structure-Activity Relationship | 2015 |
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
Topics: Anti-Bacterial Agents; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Tetracyclines; Vancomycin; Vancomycin Resistance; Visual Acuity | 2016 |
Oxazolidinone antimicrobials: a patent review (2012-2015).
Topics: Animals; Anti-Bacterial Agents; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Patents as Topic | 2016 |
Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Randomized Controlled Trials as Topic | 2008 |
Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome.
Topics: Acetamides; Anti-Bacterial Agents; Biological Availability; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic; Tissue Distribution | 2009 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
Newer antibacterial drugs for a new century.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Delivery Systems; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drugs, Investigational; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Minocycline; Oxazolidinones; Tigecycline | 2010 |
Use of linezolid in pediatrics: a critical review.
Topics: Acetamides; Adolescent; Anti-Infective Agents; Child; Child, Preschool; Clinical Trials as Topic; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Infant; Infant, Newborn; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Treatment Outcome | 2010 |
Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review.
Topics: Acetamides; Anti-Infective Agents; Child; Dose-Response Relationship, Drug; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic | 2010 |
Linezolid treatment of nosocomial bacterial infection with multiresistant Gram-positive pathogens in preterm infants: a systematic review.
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Clinical Trials as Topic; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Injections, Intravenous; Linezolid; Oxazolidinones; United States | 2010 |
[Linezolide in paediatrics].
Topics: Acetamides; Administration, Oral; Adult; Anti-Infective Agents; Child; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Oxazolidinones | 2010 |
Linezolid, the first oxazolidinone antibacterial agent.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Discovery; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Models, Biological; Models, Molecular; Oxazolidinones | 2011 |
Enterococcus gallinarum meningitis: a case report and literature review.
Topics: Acetamides; Anti-Bacterial Agents; Cerebrospinal Fluid; Craniotomy; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Surgical Wound Infection; Treatment Outcome | 2011 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Linezolid: safety and efficacy in special populations.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United Kingdom | 2011 |
Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.
Topics: Acetamides; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2011 |
Management of gram-positive bacterial infections in patients with cancer.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Minocycline; Neoplasms; Oxazolidinones; Tigecycline | 2012 |
AZD-2563 AstraZeneca.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Structure-Activity Relationship | 2002 |
[Linezolid--new antibacterial agent of the oxazolidinone group: its importance in the control of spreading and treatment of the multidrug resistance gram-positive infections].
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Streptococcus | 2002 |
Linezolid: the first oxazolidinone antimicrobial.
Topics: Acetamides; Anti-Infective Agents; Biological Availability; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Half-Life; Humans; Linezolid; Oxazolidinones | 2003 |
[Role of linezolid in antimicrobial therapy].
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Bacteria; Drug Interactions; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Methicillin Resistance; Mycobacterium; Oxazolidinones; Staphylococcus; Streptococcus | 2003 |
Linezolid: implications for neurosurgical infections.
Topics: Acetamides; Animals; Anti-Infective Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Neurosurgical Procedures; Oxazolidinones | 2003 |
Quinupristin-dalfopristin and linezolid: evidence and opinion.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance; Virginiamycin | 2003 |
[Oxazolidinones and glycopeptides].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Biotransformation; Cell Wall; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Histamine Release; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptidoglycan; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Vancomycin | 2003 |
Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Surgical Wound Infection | 2001 |
[Other antimicrobials (linezolid, quinupristin/dalfopristin)].
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Depression, Chemical; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Virginiamycin | 2003 |
Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2003 |
Linezolid in vitro: mechanism and antibacterial spectrum.
Topics: Acetamides; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2003 |
Efficacy of linezolid versus comparator therapies in Gram-positive infections.
Topics: Acetamides; Anti-Bacterial Agents; Double-Blind Method; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones; Randomized Controlled Trials as Topic | 2003 |
Oxazolidinone structure-activity relationships leading to linezolid.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Linezolid; Molecular Structure; Oxazolidinones; Structure-Activity Relationship | 2003 |
Linezolid: in infants and children with severe Gram-positive infections.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Child; Child, Preschool; Gram-Positive Bacterial Infections; Half-Life; Humans; Infant; Linezolid; Metabolic Clearance Rate; Oxazolidinones; Treatment Outcome | 2003 |
Resistance to linezolid. Are we surprised? How hard should we look?
Topics: Acetamides; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2003 |
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
Topics: Acetamides; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Half-Life; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Virginiamycin | 2003 |
Treatment of gram-positive surgical sepsis: role of the oxazolidinones.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Linezolid; Oxazolidinones; Postoperative Complications; Sepsis | 2003 |
Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin | 2003 |
Linezolid pharmacokinetics in pediatric patients: an overview.
Topics: Absorption; Acetamides; Adult; Age Factors; Anti-Infective Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Half-Life; Humans; Infant; Infant, Newborn; Infant, Premature; Linezolid; Mass Spectrometry; Oxazolidinones; Tissue Distribution | 2003 |
Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.
Topics: Acetamides; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Endocarditis, Bacterial; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Risk Assessment; Treatment Outcome; Vancomycin Resistance | 2003 |
[How effective are linezolid and telithromycin? The resistance situation of pathogenic gram positive infections in Germany].
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Germany; Gram-Positive Bacterial Infections; Humans; Ketolides; Linezolid; Macrolides; Oxazolidinones | 2004 |
[Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections | 2004 |
Oxazolidinones: activity, mode of action, and mechanism of resistance.
Topics: Acetamides; Anti-Infective Agents; Base Sequence; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Molecular Sequence Data; Mutation; Oxazolidinones; Peptidyl Transferases; RNA, Ribosomal, 23S | 2004 |
[Linezolid (Zivox), a new highly efficient antibiotic for therapy of Gram-positive infections].
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2004 |
[The role of linezolid in the therapy of infections caused by multiresistant gram-positive cocci].
Topics: Acetamides; Anti-Bacterial Agents; Drug Costs; Drug Resistance, Multiple, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Streptococcal Infections | 2004 |
New drugs for Gram-positive uropathogens.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Urinary Tract Infections; Urine | 2004 |
[Linezolid, an agent from a new class of antibiotics].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Bacteria, Anaerobic; Biological Availability; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2004 |
Enterococcus faecalis resistant to linezolid: case series and review of the literature.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones | 2004 |
Update on the use of linezolid: a pediatric perspective.
Topics: Acetamides; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones | 2004 |
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Economics, Pharmaceutical; Gram-Positive Bacterial Infections; Humans; Linezolid; Models, Economic; Oxazolidinones | 2005 |
[Linezolid, the first oxazolidinone antibiotic].
Topics: Acetamides; Anti-Infective Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcus | 2005 |
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.
Topics: Acetamides; Ampicillin Resistance; Anti-Infective Agents; Bacterial Proteins; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; Humans; Hyaluronoglucosaminidase; Linezolid; Membrane Proteins; Oxazolidinones; Phenotype; Phylogeny; Polymerase Chain Reaction; Vancomycin Resistance | 2005 |
Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2006 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Use of linezolid in children: an overview of recent advances.
Topics: Acetamides; Anti-Bacterial Agents; Child; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2006 |
Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors.
Topics: Acetamides; Adult; Anti-Infective Agents; Bacterial Proteins; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Treatment Failure; Vancomycin Resistance; Virulence; Virulence Factors | 2007 |
Linezolid for the treatment of adults with bone and joint infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Osteomyelitis; Oxazolidinones; Peripheral Nervous System Diseases | 2007 |
[Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
Topics: Acetamides; Anti-Infective Agents; Arthritis, Infectious; Bone Diseases, Infectious; Clinical Trials as Topic; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia; Prosthesis-Related Infections | 2006 |
[Linezolid].
Topics: Acetamides; Animals; Anti-Infective Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin Resistance | 2007 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
[Vancomycin resistant enterococci infection].
Topics: Acetamides; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin Resistance | 2007 |
Lactic acidosis after treatment with linezolid.
Topics: Acetamides; Acidosis, Lactic; Aged, 80 and over; Anti-Infective Agents; Cardiac Surgical Procedures; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin Resistance | 2007 |
Optimizing therapy for vancomycin-resistant enterococci (VRE).
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2007 |
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Adolescent; Adult; beta-Lactams; Drug Resistance, Multiple, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Randomized Controlled Trials as Topic | 2008 |
Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Patents as Topic; Staphylococcal Infections; Staphylococcus aureus | 2007 |
New antimicrobial agents for the treatment of Gram-positive bacterial infections.
Topics: Acetamides; Anti-Infective Agents; Cephalosporins; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones | 2008 |
[New anti-Gram+antibiotics: which role in infective endocarditis?].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Endocarditis; Gram-Positive Bacterial Infections; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
An update on the oxazolidinone antibiotics.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1999 |
New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Prescriptions; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Safety; Virginiamycin | 1999 |
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin | 2000 |
Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?
Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Drug Approval; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Virginiamycin | 2000 |
Linezolid--a new option for treating gram-positive infections.
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Linezolid; Outpatients; Oxazolidinones; Staphylococcal Infections; Vancomycin Resistance | 2000 |
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2000 |
New agents for Gram-positive bacteria.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Approval; Fluoroquinolones; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Oxazolidinones; Virginiamycin | 2000 |
[Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
Topics: Acetamides; Anti-Bacterial Agents; Erythromycin; Gram-Positive Bacterial Infections; Humans; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Respiratory Tract Infections; Streptococcus; Structure-Activity Relationship | 2000 |
Oxazolidinones: a novel class of antibiotics.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Oxazolidinones | 1999 |
Linezolid: a review of its use in the management of serious gram-positive infections.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Intestinal Absorption; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2001 |
Linezolid--a review of the first oxazolidinone.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biological Availability; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review.
Topics: Acetamides; Anti-Bacterial Agents; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2001 |
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance; Virginiamycin | 2001 |
Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cerebrospinal Fluid; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Oxazolidinones; Vancomycin Resistance | 2001 |
Linezolid for gram-positive infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Monoamine Oxidase Inhibitors; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Infections | 2001 |
Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Child; Cross Infection; Drug Combinations; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Tissue Distribution; Virginiamycin | 2001 |
[Problems and current solutions for the treatment of infections caused by gram-positive microorganisms].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance; Gram-Positive Bacterial Infections; Humans; Macrolides; Oxazolidinones; Streptogramins | 2001 |
The oxazolidinones as a new family of antimicrobial agent.
Topics: Acetamides; Adult; Animals; Anti-Bacterial Agents; Child; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Mice; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Rats | 2001 |
Linezolid: pharmacokinetic characteristics and clinical studies.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Interactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2001 |
Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid.
Topics: Acetamides; Aged; Aged, 80 and over; Anemia; Anti-Infective Agents; Clinical Trials as Topic; Female; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Polypharmacy; Product Surveillance, Postmarketing; Risk Assessment; Thrombocytopenia; Time Factors | 2001 |
Oxazolidinone antibiotics.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Protein Synthesis Inhibitors | 2001 |
Linezolid: a new antibiotic for gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Drug Costs; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections | 2001 |
Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Linezolid; Male; Meningitis, Bacterial; Oxazolidinones; Vancomycin Resistance; Ventriculostomy | 2001 |
Treatment options for vancomycin-resistant enterococcal infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Oxazolidinones; Risk Factors; Vancomycin Resistance; Virginiamycin | 2002 |
Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
Topics: Acetamides; Anti-Infective Agents; Drug Interactions; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2002 |
Therapeutic options for Gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Drugs, Investigational; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin Resistance; Virginiamycin | 2001 |
Antimicrobial susceptibility of Gram-positive bacteria: what's current, what's anticipated?
Topics: Acetamides; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cross Infection; Drug Resistance, Bacterial; Drugs, Investigational; Europe; Gram-Positive Bacterial Infections; Humans; Infection Control; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United States; Virginiamycin | 2001 |
[New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Topics: Acetamides; Anti-Bacterial Agents; Critical Illness; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2002 |
[Linezolide--an antibiotic with new action mechanism].
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
Two new treatment options for infections due to drug-resistant gram-positive cocci.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Methicillin; Oxazolidinones; Virginiamycin | 2002 |
34 trial(s) available for oxazolidin-2-one and Gram-Positive Bacterial Infections
Article | Year |
---|---|
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intestines; Linezolid; Male; Middle Aged; Oxazolidinones; Staphylococcus; Streptococcus | 2014 |
Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Body Mass Index; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Dosage Calculations; Fasting; Female; Food-Drug Interactions; Gram-Positive Bacterial Infections; Healthy Volunteers; Humans; Linezolid; Male; Models, Statistical; Oxazolidinones; Patient Safety; Pyridones | 2017 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin | 2009 |
Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.
Topics: Acetamides; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Orthotic Devices; Osteomyelitis; Oxazolidinones; Prosthesis-Related Infections; Rifampin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2009 |
Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
Topics: Acetamides; Adult; Anti-Infective Agents; Drug-Related Side Effects and Adverse Reactions; Enterococcus; Female; Graft Survival; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Linezolid; Male; Middle Aged; Models, Biological; Oxazolidinones; Retrospective Studies; Time Factors; Transplantation, Homologous; Vancomycin Resistance | 2009 |
Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Treatment Outcome; Vancomycin | 2010 |
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pediatrics; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2011 |
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2011 |
Efficacy and safety of linezolid in liver transplant patients.
Topics: Acetamides; Adult; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Incidence; Linezolid; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Thrombocytopenia; Treatment Outcome; Vancomycin Resistance | 2011 |
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Cellulitis; Double-Blind Method; Drug Administration Schedule; Female; Fusidic Acid; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2011 |
Lack of an effect of standard and supratherapeutic doses of linezolid on QTc interval prolongation.
Topics: Acetamides; Adult; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Moxifloxacin; Oxazolidinones; Quinolines; Young Adult | 2011 |
Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome | 2003 |
[The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; International Cooperation; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Treatment Outcome | 2003 |
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Adolescent; Cefadroxil; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Probability; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Skin Diseases, Infectious; Treatment Outcome | 2003 |
Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial.
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Hospital Costs; Humans; Injections, Intramuscular; Injections, Intravenous; Linezolid; Male; Mexico; Middle Aged; Oxazolidinones; South America; Teicoplanin | 2003 |
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Topics: Acetamides; Bacteremia; Child; Child, Preschool; Confidence Intervals; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Probability; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2003 |
Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Treatment Outcome; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Linezolid for the treatment of complicated skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Hematologic effects of linezolid in young children.
Topics: Acetamides; Administration, Oral; Age Factors; Anemia; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Hemoglobins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Neutropenia; Oxazolidinones; Thrombocytopenia; Vancomycin | 2003 |
Safety and tolerability of linezolid in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefadroxil; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Gram-Positive Bacterial Infections; Headache; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Multicenter Studies as Topic; Otitis Media; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Skin Diseases, Bacterial | 2003 |
Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Child; Child, Preschool; Empathy; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Organ Transplantation; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2003 |
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Critical Care; Critical Illness; Cross Infection; Double-Blind Method; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Pneumonia, Bacterial; Respiratory Tract Infections; Sepsis; Soft Tissue Infections; Teicoplanin; Treatment Outcome | 2004 |
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Costs and Cost Analysis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Teicoplanin | 2004 |
Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
Topics: Acetamides; Adult; Aged; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pilot Projects; Prospective Studies; Vancomycin Resistance; Virginiamycin | 2004 |
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
Topics: Acetamides; Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Prospective Studies; Risk Assessment; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2004 |
An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Cohort Studies; Costs and Cost Analysis; Europe; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Teicoplanin | 2004 |
Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.
Topics: Acetamides; Cellulitis; Consumer Product Safety; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Protein Synthesis Inhibitors; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
[Problems of prophylaxis and treatment of infectious complications in reconstructive surgery].
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Plastic Surgery Procedures; Surgical Wound Infection | 2005 |
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Neoplasms; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 1997 |
Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Epidural Abscess; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazoles; Oxazolidinones; Parotitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2000 |
291 other study(ies) available for oxazolidin-2-one and Gram-Positive Bacterial Infections
Article | Year |
---|---|
Clonal spread and horizontal transfer mediate dissemination of phenicol-oxazolidinone-tetracycline resistance gene poxtA in enterococci isolates from a swine farm in China.
Topics: Animals; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Enterococcaceae; Enterococcus faecalis; Enterococcus faecium; Farms; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Oxazolidinones; Swine; Swine Diseases; Tetracycline Resistance | 2021 |
Characterization of a novel RepA_N-family plasmid harbouring the phenicol-oxazolidinone resistance gene optrA in Enterococcus faecalis ST16 high-risk clone of goat origin.
Topics: Animals; Anti-Bacterial Agents; Clone Cells; Drug Resistance, Bacterial; Enterococcus faecalis; Goat Diseases; Goats; Gram-Positive Bacterial Infections; Interleukins; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Plasmids | 2022 |
Fattening Pigs Are a Reservoir of Florfenicol-Resistant Enterococci Harboring Oxazolidinone Resistance Genes.
Topics: Animals; Anti-Bacterial Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Oxazolidinones; Swine; Thiamphenicol | 2022 |
A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.
Topics: Animals; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Oxazolidinones; Tetrazoles | 2022 |
Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Switzerland | 2022 |
Linezolid-Resistant Enterococcus faecalis of Chicken Origin Harbored Chromosome-Borne
Topics: Animals; Anti-Bacterial Agents; Chickens; Chromosomes; Drug Resistance, Bacterial; Enterococcus faecalis; Genes, Bacterial; Gram-Positive Bacterial Infections; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Plasmids | 2023 |
Rapid culture-based LNZ test for detection of linezolid susceptibility/resistance in staphylococci and enterococci.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus | 2023 |
Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Staphylococcal Infections; Tetrazoles; Vancomycin Resistance; Vancomycin-Resistant Staphylococcus aureus | 2020 |
Co-existence of the oxazolidinone resistance genes cfr and optrA on two transferable multi-resistance plasmids in one Enterococcus faecalis isolate from swine.
Topics: Animals; Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Swine | 2020 |
The first case of teeth discoloration induced by linezolid in children in China Mainland.
Topics: Acetamides; Anti-Bacterial Agents; Child; China; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2020 |
Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin.
Topics: Anti-Bacterial Agents; Burns; Daptomycin; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Teicoplanin; Tetrazoles; Tigecycline | 2020 |
Coexistence of the Oxazolidinone Resistance-Associated Genes
Topics: Animals; Brazil; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Oxazolidinones; Swine; United States | 2020 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |
Detection of phenicol-oxazolidinone resistance gene optrA in Aerococcus viridans from bovine faeces, Italy.
Topics: Aerococcus; Animals; Anti-Bacterial Agents; Cattle; Enterococcus faecalis; Feces; Gram-Positive Bacterial Infections; Oxazolidinones; Thiamphenicol | 2021 |
Determination of Tedizolid susceptibility interpretive criteria for gram-positive pathogens according to clinical and laboratory standards institute guidelines.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Tetrazoles | 2018 |
Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing.
Topics: Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Tetrazoles; Virulence Factors | 2018 |
In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Tetrazoles; Vancomycin | 2018 |
Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
Topics: Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Epidemiological Monitoring; Global Health; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Typing; Mutation; Oxazolidinones; Plasmids; RNA, Bacterial; RNA, Ribosomal, 23S; Whole Genome Sequencing | 2018 |
Synthesis and antibacterial activity evaluation of novel biaryloxazolidinone analogues containing a hydrazone moiety as promising antibacterial agents.
Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hep G2 Cells; Humans; Hydrazones; Microsomes, Liver; Molecular Docking Simulation; Oxazolidinones | 2018 |
Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates.
Topics: Anti-Infective Agents; Chloramphenicol; Conjugation, Genetic; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gene Order; Gene Transfer, Horizontal; Genes, Bacterial; Genetic Variation; Germany; Gram-Positive Bacterial Infections; Humans; Interspersed Repetitive Sequences; Oxazolidinones; Polymerase Chain Reaction; Retrospective Studies; Whole Genome Sequencing | 2018 |
Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Italy; Microbial Sensitivity Tests; Oxazolidinones; Swine; Swine Diseases; Tetracycline | 2019 |
Efficacy of Tedizolid against Enterococci and Staphylococci, Including
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Disease Models, Animal; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcus; Tetrazoles | 2019 |
Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014-17).
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Europe; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Tetrazoles; United States | 2019 |
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Treatment Outcome; Young Adult | 2019 |
Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Greece; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones | 2019 |
Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; China; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Sequence Analysis, DNA; Tetracycline | 2019 |
Comparative
Topics: Anti-Bacterial Agents; Asian People; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Inpatients; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Tetrazoles | 2019 |
Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; China; Conjugation, Genetic; Enterococcus faecium; Farms; Feces; Gram-Positive Bacterial Infections; Host Specificity; Oxazolidinones; Plasmids; Swine; Swine Diseases | 2019 |
Severe sepsis caused by a linezolid-resistant Enterococcus faecium in a 10-year-old girl after multiple trauma.
Topics: Acetamides; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Multiple Trauma; Oxazolidinones; Sepsis | 2013 |
Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
Topics: Acetamides; Administration, Topical; Anti-Infective Agents; Corneal Ulcer; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Ophthalmic Solutions; Oxazolidinones; Retrospective Studies; Staphylococcus; Streptococcus mitis; Vancomycin Resistance | 2013 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Oxazolidinones; Prevalence; Vancomycin; Young Adult | 2013 |
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Cells; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Plasma; Prospective Studies; Risk Assessment | 2013 |
Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Rabbits; Tigecycline | 2013 |
Emergence of mutation-based linezolid-resistant invasive Enterococcus faecalis in a haemodialysis patient in Norway.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Mutation; Norway; Oxazolidinones; Renal Dialysis | 2014 |
Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.
Topics: Acetamides; Animals; Chicago; Disease Models, Animal; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Humans; Kaplan-Meier Estimate; Linezolid; Moths; Oxazolidinones; Time Factors; Vancomycin; Vancomycin Resistance | 2013 |
Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child, Preschool; China; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Oxazolidinones; Plasmids; Ribosomal Protein L3; Ribosomal Proteins; RNA, Ribosomal, 23S; Staphylococcus; Young Adult | 2013 |
Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance.
Topics: Acetamides; Anti-Infective Agents; Bacterial Proteins; Biofilms; Carrier Proteins; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Membrane Proteins; Mexico; Oligopeptides; Oxazolidinones; Virulence; Virulence Factors | 2013 |
Emergence and long-lasting persistence of linezolid-resistant Enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid.
Topics: Acetamides; Acute Disease; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukemia; Linezolid; Male; Neutropenia; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S | 2014 |
Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Female; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mutation; Ontario; Oxazolidinones | 2013 |
Glans necrosis produced by trauma during masturbation.
Topics: Acetamides; Anti-Infective Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Masturbation; Middle Aged; Necrosis; Oxazolidinones; Penis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
[Retrospective analysis of the Gram-positive bacteria-infected cases in the Department of Hematology].
Topics: Acetamides; Adult; Aged; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2013 |
Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Streptococcus; United States | 2014 |
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).
Topics: Acetamides; Anti-Infective Agents; Global Health; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Population Surveillance | 2014 |
Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Computer Simulation; Critical Illness; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Oxazolidinones; Streptococcus pneumoniae | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Neoplasms; Oxazolidinones; Vancomycin | 2014 |
Prevalence and detection of mixed-population enterococcal bacteremia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Coinfection; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Multilocus Sequence Typing; Oxazolidinones; Prevalence; Treatment Outcome; Vancomycin Resistance | 2014 |
[In vitro antimicrobial susceptibility in Enterococcus faecalis and Enterococcus faecium isolated from hospitalized patients].
Topics: Acetamides; Bacterial Typing Techniques; Cross Infection; Cuba; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Tertiary Care Centers; Vancomycin Resistance | 2014 |
Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.
Topics: Acetamides; Adult; Aged, 80 and over; Anti-Bacterial Agents; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Norway; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Virulence Factors | 2014 |
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Child; Child, Preschool; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Inpatients; Linezolid; Male; Monte Carlo Method; Oxazolidinones; Plasma; Retrospective Studies; Tertiary Care Centers | 2015 |
Early lactic acidosis associated with linezolid therapy in paediatric patients.
Topics: Acetamides; Acidosis, Lactic; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Infant; Linezolid; Male; Oxazolidinones; Time Factors; Treatment Outcome | 2014 |
Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; China; Drug Resistance, Bacterial; Enterococcus; Gene Transfer, Horizontal; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Oxazolidinones; Point Mutation; Ribosomal Proteins; RNA, Ribosomal, 23S; Staphylococcus | 2014 |
Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
Topics: Acetamides; Anti-Bacterial Agents; Epidemiological Monitoring; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Organophosphates; Oxazoles; Oxazolidinones; Ribosomal Proteins; RNA, Ribosomal, 23S; United States | 2015 |
Linezolid bladder irrigation as adjunctive treatment for a vancomycin-resistant Enterococcus faecium catheter-associated urinary tract infection.
Topics: Acetamides; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Therapeutic Irrigation; Urinary Bladder; Urinary Tract Infections; Vancomycin Resistance | 2015 |
A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Cluster Analysis; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gene Transfer, Horizontal; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology; Transformation, Bacterial | 2015 |
[Vancomycin-resistant enterococci: increased mortality with tigecycline?].
Topics: Acetamides; Daptomycin; Gram-Positive Bacterial Infections; Humans; Minocycline; Oxazolidinones; Vancomycin-Resistant Enterococci | 2015 |
[Vancomycin-resistant enterococci: increased mortality with tigecyclin?].
Topics: Acetamides; Daptomycin; Gram-Positive Bacterial Infections; Humans; Minocycline; Oxazolidinones; Vancomycin-Resistant Enterococci | 2015 |
Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gene Dosage; Gene Expression; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Oxazolidinones; Phylogeny; Recombinant Proteins; Ribosomal Proteins; RNA, Ribosomal, 23S; Staphylococcus aureus; United States | 2015 |
Detection in Italy of two clinical Enterococcus faecium isolates carrying both the oxazolidinone and phenicol resistance gene optrA and a silent multiresistance gene cfr.
Topics: Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Italy; Oxazolidinones | 2016 |
Genetic environment of the transferable oxazolidinone/phenicol resistance gene optrA in Enterococcus faecalis isolates of human and animal origin.
Topics: Animals; Anti-Infective Agents; Chickens; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Bacterial; Enterococcus faecalis; Gene Transfer, Horizontal; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Plasmids; Sequence Analysis, DNA; Swine; Thiamphenicol | 2016 |
[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Infant, Newborn; Linezolid; Male; Middle Aged; Neonatal Sepsis; Oxazolidinones; Platelet Count; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin | 2016 |
Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.
Topics: Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Oxazolidinones; Public Health Surveillance | 2016 |
High detection rate of the oxazolidinone resistance gene optrA in Enterococcus faecalis isolated from a Chinese anorectal surgery ward.
Topics: Anti-Infective Agents; Asian People; China; Drug Resistance, Bacterial; Enterococcus faecalis; Genes, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Oxazolidinones; Prevalence | 2016 |
Detection of novel oxazolidinone and phenicol resistance gene optrA in enterococcal isolates from food animals and animal carcasses.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Cattle; Chickens; Chloramphenicol; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecalis; Feces; Food Microbiology; Gram-Positive Bacterial Infections; Linezolid; Multilocus Sequence Typing; Mutation; Oxazolidinones; Republic of Korea; Swine; Thiamphenicol | 2017 |
Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis.
Topics: Acetamides; Aged; Anti-Infective Agents; Endocarditis, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Treatment Failure | 2008 |
Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Drug Administration Schedule; Enterococcus; General Surgery; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.
Topics: Acetamides; Anti-Bacterial Agents; Bile Ducts; Cholangitis; Chromatography, High Pressure Liquid; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Transplantation; Male; Middle Aged; Oxazolidinones; Plasma; Vancomycin Resistance | 2009 |
Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Environmental Microbiology; Feces; Female; Genotype; Gram-Positive Bacterial Infections; Greece; Hospitals, University; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Oxazolidinones; Point Mutation; Polymorphism, Restriction Fragment Length; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin Resistance | 2009 |
Linezolid for the treatment of drug-resistant infections.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Economics, Pharmaceutical; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2008 |
[A case of vancomycin resistant Leuconostoc meningitis].
Topics: Acetamides; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Linezolid; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Spinal Puncture; Subarachnoid Hemorrhage; Vancomycin Resistance | 2008 |
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Decision Trees; Drug Monitoring; France; Gram-Positive Bacterial Infections; Humans; Inpatients; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections | 2009 |
Impact of prolonged treatment with linezolid on the human gut flora.
Topics: Acetamides; Aged; Candida; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intestinal Mucosa; Knee Prosthesis; Linezolid; Male; Osteomyelitis; Oxazolidinones; Prosthesis-Related Infections; Treatment Outcome | 2009 |
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin Resistance; Young Adult | 2009 |
Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacteremia; Crohn Disease; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Treatment Outcome; Vancomycin | 2009 |
ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Asia; Australia; Canada; Drug Resistance, Bacterial; Europe; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Latin America; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2009 |
Use of linezolid in critically ill patients admitted to intensive care units.
Topics: Acetamides; Anti-Bacterial Agents; Catheter-Related Infections; Community-Acquired Infections; Critical Care; Critical Illness; Cross Infection; Disease Susceptibility; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Prospective Studies; Staphylococcal Infections; Thrombocytopenia; Treatment Outcome | 2009 |
Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Teicoplanin | 2009 |
Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Comorbidity; Disease Outbreaks; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; United States; Vancomycin Resistance; Virginiamycin | 2009 |
Linezolid vancomycin resistant Enterococcus isolated from clinical samples in Tehran hospitals.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Iran; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Prevalence; Serum Bactericidal Test; Teicoplanin; Vancomycin Resistance | 2009 |
Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Spain; Young Adult | 2009 |
[Linezolid-induced lactic acidosis].
Topics: Acetamides; Acidosis, Lactic; Aged; Anti-Bacterial Agents; Comorbidity; Dyspnea; Endocarditis, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones | 2009 |
Linezolid surveillance program results for 2008 (LEADER Program for 2008).
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Prevalence; United States | 2009 |
Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
Topics: Acetamides; Anti-Bacterial Agents; Asia; Canada; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Latin America; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S | 2009 |
Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Carrier State; Clindamycin; Comorbidity; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Plasmids; Prevalence; Retrospective Studies; Risk Factors; Vancomycin Resistance | 2010 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
[In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
Topics: Acetamides; Anti-Infective Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin Resistance | 2009 |
Efficacy and safety of linezolid in immunocompromised children with cancer.
Topics: Acetamides; Age Factors; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Greece; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2010 |
[Efficacy and tolerability of linezolid therapy in the treatment of orthopedic implant infections caused by gram-positive multiresistant cocci].
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Female; Fracture Fixation, Internal; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Osteomyelitis; Oxazolidinones; Prosthesis-Related Infections; Retrospective Studies | 2010 |
[Linezolid in the treatment of gram positive coccal infections in critical patients].
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Critical Care; Critical Illness; Cross Infection; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones | 2010 |
Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Prognosis; Risk Factors; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2010 |
Successful treatment of vancomycin-resistant Enterococcus faecium ventriculitis with combined intravenous and intraventricular chloramphenicol in a newborn.
Topics: Acetamides; Anti-Bacterial Agents; Cerebral Ventricles; Cerebrospinal Fluid; Chloramphenicol; Encephalitis; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Head; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intraventricular; Linezolid; Lumbosacral Region; Magnetic Resonance Imaging; Oxazolidinones; Pelvis; Radiography; Treatment Outcome; Vancomycin Resistance | 2010 |
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Male; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2010 |
Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovative.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Computational Biology; Daptomycin; Drug Delivery Systems; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Forecasting; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Minocycline; Oxazolidinones; Pharmacogenetics; Systems Biology; Tigecycline; Virginiamycin | 2010 |
Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.
Topics: Acetamides; Aged; Anti-Infective Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin Resistance | 2011 |
Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Global Health; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Population Surveillance; Species Specificity | 2010 |
Linezolid levels in a patient with biliary tract sepsis, severe hepatic failure and acute kidney injury on sustained low-efficiency dialysis (SLED).
Topics: Acetamides; Acute Kidney Injury; Aged; Anti-Bacterial Agents; APACHE; Biliary Tract Diseases; Cholecystectomy; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Failure; Male; Oxazolidinones; Renal Dialysis; Sepsis; Vancomycin Resistance | 2010 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2010 |
[Clinical analysis of 102 blood disease patients with gram positive cocci infection treated with Linezolid].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Diseases; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus | 2010 |
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Data Interpretation, Statistical; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Multivariate Analysis; Oxazolidinones; Prognosis; Retrospective Studies; Treatment Outcome; Vancomycin Resistance | 2010 |
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Linezolid; Male; Metabolic Clearance Rate; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Vancomycin | 2011 |
Co-emergence of linezolid-resistant Staphylococcus aureus and Enterococcus faecium in a patient with methicillin-resistant S. aureus pneumonic sepsis.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fatal Outcome; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; RNA, Ribosomal, 23S; Shock, Septic; Staphylococcus aureus; Time Factors | 2011 |
Linezolid for endocarditis: a case series of 14 patients.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Serum Bactericidal Test; Treatment Outcome | 2011 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
Linezolid-resistant enterococci in Greece: epidemiological characteristics.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Greece; Hospitals; Humans; Intensive Care Units; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Phenotype; RNA, Ribosomal, 23S; Sequence Analysis, RNA | 2011 |
[Role of daptomycin in the treatment of infections in patients with hematological malignancies].
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Daptomycin; Databases, Factual; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Kidney Diseases; Linezolid; Microbial Sensitivity Tests; Minocycline; Multicenter Studies as Topic; Neutropenia; Oxazolidinones; Registries; Retrospective Studies; Risk Factors; Tigecycline; Treatment Outcome | 2010 |
Early life-threatening lactic acidosis following a single infusion of linezolid.
Topics: Acetamides; Acidosis, Lactic; Aged, 80 and over; Critical Care; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Linezolid; Male; Oxazolidinones | 2011 |
Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
Topics: Acetamides; Anti-Bacterial Agents; Czech Republic; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcus pneumoniae; Tigecycline | 2011 |
Clinical experience with linezolid in infants and children.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Oxazolidinones; Treatment Outcome | 2011 |
[Linezolid use in an intensive care unit].
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Utilization; Female; France; Gram-Positive Bacterial Infections; Guideline Adherence; Hospitals, University; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Practice Guidelines as Topic; Retrospective Studies | 2011 |
Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Treatment Outcome | 2011 |
Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Italy; Linezolid; Male; Mycobacterium; Mycobacterium Infections; Oxazolidinones; Retrospective Studies; Treatment Outcome | 2011 |
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Usefulness of monitoring linezolid trough serum concentration in prolonged treatments.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Musculoskeletal Diseases; Orthopedic Procedures; Oxazolidinones; Prosthesis-Related Infections; Treatment Outcome | 2011 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Vancomycin | 2012 |
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Streptococcus pneumoniae; Tigecycline; Treatment Outcome; United States; Vancomycin Resistance | 2011 |
Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Databases, Factual; Drug Interactions; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Serotonin; Serotonin Agents | 2012 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Risk factors associated with linezolid-nonsusceptible enterococcal infections.
Topics: Acetamides; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Risk Factors | 2012 |
[Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Care; Critical Illness; Daptomycin; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2012 |
Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Greece; Hospitals, University; Humans; Intensive Care Units; Linezolid; Molecular Epidemiology; Molecular Typing; Oxazolidinones; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2012 |
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Topics: Acetamides; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Incidence; Linezolid; Male; Middle Aged; Oxazolidinones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Vancomycin; Vancomycin Resistance | 2012 |
[Enterococcus faecalis meningitis after spinal anesthesia successfully managed with linezolid].
Topics: Acetamides; Anesthesia, Spinal; Anti-Infective Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Remission Induction; Young Adult | 2012 |
Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Comment on: Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Acetamides; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Typing; Oxazolidinones | 2012 |
A mixed infection of Leuconostoc lactis and vancomycin-resistant Enterococcus in a liver transplant recipient.
Topics: Acetamides; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Linezolid; Liver Transplantation; Male; Middle Aged; Oxazolidinones; Sepsis; Vancomycin Resistance | 2012 |
Linezolid-resistant clinical isolates of meticillin-resistant coagulase-negative staphylococci and Enterococcus faecium from China.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Coagulase; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
[In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
Topics: Acetamides; Anti-Bacterial Agents; Enterococcaceae; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Rectum; Teicoplanin; Turkey; Vancomycin Resistance | 2012 |
[Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Mutation; Oxazolidinones; Pressure Ulcer; Turkey; Vancomycin Resistance | 2012 |
Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin Resistance; Virginiamycin | 2013 |
Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis.
Topics: Acetamides; Amputation Stumps; Anti-Bacterial Agents; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Renal Dialysis; Time Factors; Treatment Outcome | 2012 |
[Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
Topics: Acetamides; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Population Surveillance; Serotyping; Teicoplanin; Vancomycin Resistance | 2012 |
Vancomycin-resistant enterococcal meningitis in an autologous stem cell transplant recipient cured with linezolid.
Topics: Acetamides; Anti-Infective Agents; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Transplantation, Autologous; Treatment Outcome; Vancomycin Resistance | 2013 |
[Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Culture Media; Daptomycin; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Turkey; Vancomycin Resistance; Young Adult | 2012 |
Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin | 2012 |
Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Administration, Intravenous; Anti-Bacterial Agents; Cerebral Ventriculitis; Daptomycin; Dose-Response Relationship, Drug; Drainage; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2012 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms.
Topics: Acetamides; Anti-Bacterial Agents; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Guideline Adherence; Humans; Incidence; Linezolid; Organizational Policy; Oxazolidinones; Prospective Studies; Tertiary Care Centers | 2013 |
Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).
Topics: Acetamides; Anti-Bacterial Agents; Diffusion; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Latin America; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Species Specificity; Vancomycin Resistance | 2002 |
Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis.
Topics: Acetamides; Anti-Bacterial Agents; Encephalitis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Infant; Linezolid; Male; Oxazolidinones; Vancomycin Resistance; Ventriculoperitoneal Shunt | 2002 |
[Enterococcus faecium cholangitis resistant to vancomycin and quinupristin-dalfopristin].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Spain; Treatment Failure; Vancomycin Resistance; Virginiamycin | 2002 |
Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Risk Factors; Vancomycin Resistance | 2002 |
Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Austria; Base Sequence; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Oxazolidinones; Polymerase Chain Reaction; Sensitivity and Specificity | 2002 |
Summaries for patients. Linezolid.
Topics: Acetamides; Anti-Infective Agents; Biological Availability; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Half-Life; Humans; Linezolid; Oxazolidinones | 2003 |
Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals.
Topics: Acetamides; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Kuwait; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; Prevalence; Vancomycin Resistance | 2003 |
Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific.
Topics: Acetamides; Anti-Bacterial Agents; Asia, Eastern; Australia; Data Collection; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Streptococcus pneumoniae | 2003 |
Therapeutic efficacy of linezolid in extended clinical practice.
Topics: Acetamides; Anti-Infective Agents; Drug Labeling; Drug Storage; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Assessment; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Temperature | 2003 |
Isolation of linezolid-resistant Enterococcus faecalis.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Prosthesis-Related Infections | 2003 |
Linezolid: new preparation. In severe gram-positive infections.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome | 2003 |
First report of the activity of linezolid against Portuguese enterococci from human, animal and environmental sources.
Topics: Acetamides; Animals; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Portugal | 2003 |
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia.
Topics: Acetamides; Adult; Aged; Area Under Curve; Chi-Square Distribution; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Neoplasms; Neutropenia; Oxazolidinones; Prospective Studies; Statistics, Nonparametric | 2003 |
Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Drug Interactions; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Oxazolidinones; Protein Synthesis Inhibitors | 2003 |
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Topics: Acetamides; Aged; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Vancomycin; Vancomycin Resistance | 2003 |
Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Infant; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones | 2003 |
Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2003 |
In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Topics: Abscess; Acetamides; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Dipeptidases; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hexosyltransferases; Kidney; Linezolid; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxazolidinones; Penicillin-Binding Proteins; Peptidyl Transferases; Vancomycin; Vancomycin Resistance | 2003 |
Failure of linezolid treatment for enterococcal endocarditis.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones | 2003 |
Use of linezolid in children. Introduction.
Topics: Acetamides; Age Factors; Anti-Infective Agents; Child; Child, Preschool; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Linezolid; Oxazolidinones | 2003 |
Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis.
Topics: Acetamides; Anti-Bacterial Agents; Dialysis Solutions; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Linezolid; Male; Middle Aged; Oxazolidinones; Peritoneal Dialysis; Peritonitis; Vancomycin Resistance | 2003 |
Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs.
Topics: Acetamides; Aged; Base Sequence; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus faecalis; Genes, Bacterial; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Polymerase Chain Reaction; Stroke | 2003 |
Linezolid: the first oxazolidinone antimicrobial.
Topics: Acetamides; Anti-Infective Agents; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Prescription Fees | 2003 |
Linezolid: the first oxazolidinone antimicrobial.
Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2003 |
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Area Under Curve; Comorbidity; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2003 |
Delayed discovery of linezolid-resistant, vancomycin-resistant Enterococcus faecium: lessons learned.
Topics: Acetamides; Aged; Aged, 80 and over; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2004 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
Antimicrobials in the treatment of orthopaedic prosthetic infections.
Topics: Acetamides; Anti-Infective Agents; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Prosthesis-Related Infections | 2004 |
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Fetal Blood; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Stem Cell Transplantation | 2004 |
Current and new antimicrobial agents.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Virginiamycin | 2004 |
Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitis.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Debridement; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Osteomyelitis; Oxazolidinones; Postoperative Complications; Skin Transplantation; Soft Tissue Infections; Staphylococcus aureus; Surgical Flaps; Surgical Procedures, Operative; Treatment Outcome; Vancomycin Resistance; Wounds and Injuries | 2004 |
Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Combinations; Female; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Linezolid; Male; Middle Aged; Orthopedics; Oxazolidinones; Postoperative Complications; Prospective Studies; Thrombocytopenia; Time; Vancomycin | 2004 |
Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fatal Outcome; Female; Germany; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pancreatitis, Acute Necrotizing; Peritonitis; Shock, Septic | 2004 |
Susceptibility to quinupristin-dalfopristin and linezolid in 839 clinical isolates of Gram-positive cocci from Norway.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Norway; Oxazolidinones; Virginiamycin | 2004 |
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Linezolid; Lipoglycopeptides; Methicillin Resistance; Mice; Muscle, Skeletal; Nafcillin; Neutropenia; Oxazolidinones; Protein Binding; Staphylococcal Infections; Subcutaneous Tissue; Vancomycin | 2004 |
Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
Topics: Acetamides; Anti-Bacterial Agents; Drug Utilization; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin Resistance; Virginiamycin | 2004 |
Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
Topics: Acetamides; Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Anti-Bacterial Agents; Case-Control Studies; Chronic Disease; Drug Administration Schedule; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Retrospective Studies; Risk Factors | 2004 |
Linezolid therapy for orthopedic infections.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Bone Diseases, Infectious; Databases, Factual; Debridement; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minnesota; Oxazolidinones; Retrospective Studies; Treatment Outcome | 2004 |
Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus | 2004 |
Enterococcal bacteremia complicating pemphigus vulgaris: successful treatment with linezolid.
Topics: Acetamides; Adult; Bacteremia; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Pemphigus; Severity of Illness Index; Treatment Outcome | 2004 |
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
Topics: Acetamides; Aged; Drug Administration Schedule; Gram-Positive Bacterial Infections; Hemofiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Linezolid; Male; Middle Aged; Oxazolidinones; Peritonitis; Surgical Wound Infection | 2004 |
Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
Topics: Acetamides; Anti-Infective Agents; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; HIV Infections; Humans; Kidney Transplantation; Linezolid; Male; Middle Aged; Opportunistic Infections; Oxazolidinones; Vancomycin Resistance; Viral Load | 2004 |
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin | 2005 |
Linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Child; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Protein Biosynthesis; Protein Synthesis Inhibitors | 2004 |
[Prolonged treatment with linezolid with good hematologic tolerability].
Topics: Acetamides; Aged; Anti-Infective Agents; Blood Platelets; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Oxazolidinones; Staphylococcal Infections; Time Factors | 2004 |
Surveillance of linezolid resistance in Germany, 2001-2002.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Female; Germany; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Population Surveillance | 2005 |
Linezolid in the treatment of Gram-positive prosthetic joint infections.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Hip Prosthesis; Humans; Joint Diseases; Knee Prosthesis; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Retrospective Studies | 2005 |
First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Oxazolidinones; Taiwan; Vancomycin | 2005 |
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2005 |
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Colony Count, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Models, Biological; Oxazolidinones; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2005 |
Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
Topics: Acetamides; Anti-Infective Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Latin America; Linezolid; Microbial Sensitivity Tests; North America; Oxazolidinones; Population Surveillance; South America | 2005 |
In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria.
Topics: Acetamides; Aerobiosis; Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazolidinones | 2005 |
Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Linezolid; Microbial Sensitivity Tests; Neoplasms; Oxazolidinones; Virginiamycin | 2005 |
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Global Health; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Product Surveillance, Postmarketing | 2005 |
Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin Resistance | 2006 |
Emergence of linezolid-resistant enterococci in a neutropenic patient.
Topics: Acetamides; Adult; Anti-Infective Agents; Bacteremia; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones | 2006 |
Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Transplantation; Male; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Time Factors; Vancomycin Resistance; Virginiamycin | 2005 |
Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Brain Abscess; Brain Neoplasms; Capnocytophaga; Combined Modality Therapy; Craniotomy; Cross Infection; Drainage; Drug Evaluation; Drug Resistance; Epilepsy, Tonic-Clonic; Frontal Lobe; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Mandibular Diseases; Meningitis, Bacterial; Middle Aged; Oligodendroglioma; Osteolysis; Oxazolidinones; Postoperative Complications; Sinusitis | 2005 |
The pharmacokinetics of linezolid in the non-inflamed human eye.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones | 2005 |
In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program.
Topics: Acetamides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Product Surveillance, Postmarketing; United States | 2005 |
Mitochondrial toxicity associated with linezolid.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Asthenia; Brain Abscess; Electron Transport Complex II; Electron Transport Complex IV; Gram-Positive Bacterial Infections; Humans; Lactic Acid; Linezolid; Male; Mitochondria; Mitochondrial Diseases; Oxazolidinones; Prosthesis-Related Infections | 2005 |
High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
Topics: Acetamides; Aged; Aged, 80 and over; Anemia; Anti-Infective Agents; Case-Control Studies; Female; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Linezolid; Male; Middle Aged; Oxazolidinones; Renal Dialysis; Retrospective Studies; Thrombocytopenia | 2006 |
Linezolid-resistant E. faecium isolated from an open joint fracture: a report of the first isolate from Italy?
Topics: Accidents, Traffic; Acetamides; Adult; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecium; Female; Fractures, Open; Gram-Positive Bacterial Infections; Humans; Italy; Linezolid; Oxazolidinones; Patella | 2005 |
Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms.
Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Gram-Positive Bacterial Infections; Hospital Costs; Humans; Linezolid; Models, Economic; Oxazolidinones; Teicoplanin | 2005 |
Conformational constraint in oxazolidinone antibacterials. Part 2: Synthesis and structure-activity studies of oxa-, aza-, and thiabicyclo[3.1.0]hexylphenyl oxazolidinones.
Topics: Amides; Animals; Anti-Bacterial Agents; Aza Compounds; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Molecular Conformation; Oxazolidinones; Structure-Activity Relationship; Sulfhydryl Compounds | 2006 |
Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.
Topics: Acetamides; Animals; Aortic Valve; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Heart Valve Diseases; Linezolid; Oxazolidinones; Rabbits; Streptococcal Infections | 2006 |
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2006 |
Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates.
Topics: Acetamides; Drug Resistance, Bacterial; Enterococcus faecium; Female; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Linezolid; Male; Oxazolidinones; Premature Birth; Safety | 2006 |
Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Conformation; Oxazolidinones; Stereoisomerism | 2006 |
Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin Resistance | 2006 |
Linezolid in the treatment of brain abscess due to Peptostreptococcus.
Topics: Acetamides; Adult; Anti-Infective Agents; Brain Abscess; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Peptostreptococcus; Thalamus; Treatment Outcome | 2006 |
Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.
Topics: Acetamides; Anti-Bacterial Agents; Bacteriological Techniques; Base Sequence; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 23S | 2006 |
Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
Topics: Acetamides; Alleles; Base Sequence; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Italy; Linezolid; Molecular Epidemiology; Oxazolidinones; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin Resistance | 2006 |
Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Oxazolidinones; Retrospective Studies | 2006 |
Early experience with linezolid for infections in orthopaedics.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Orthopedic Procedures; Oxazolidinones; Prosthesis-Related Infections; Recurrence; Reoperation; Surgical Wound Infection; Treatment Outcome | 2006 |
Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Vancomycin | 2006 |
First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Base Sequence; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Korea; Linezolid; Male; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Polymorphism, Restriction Fragment Length; Treatment Outcome; Vancomycin Resistance | 2006 |
In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.
Topics: Acetamides; Anti-Bacterial Agents; Critical Illness; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Inpatients; Intensive Care Units; Length of Stay; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Teicoplanin; Treatment Outcome | 2006 |
Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
Topics: Acetamides; Aged; Anti-Infective Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Oxazolidinones; Vancomycin Resistance | 2006 |
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Topics: Academic Medical Centers; Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Topics: Academic Medical Centers; Acetamides; Adult; Aged; Aged, 80 and over; Alabama; Anti-Infective Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2006 |
Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Time Factors; Treatment Outcome | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Linezolid-resistant Enterococcus faecalis: first report in Spain.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Oxazolidinones; Spain | 2006 |
EUCAST Technical Note on linezolid.
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Enterococcus; Europe; Gram-Positive Bacterial Infections; Humans; Infusion Pumps; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2006 |
A case of Enterococcus faecalis prosthetic joint infection: a rare and difficult infection to treat.
Topics: Acetamides; Anti-Infective Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Knee Prosthesis; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections | 2006 |
Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Acetamides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Population Surveillance | 2007 |
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2007 |
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2007 |
Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital.
Topics: Acetamides; Adult; Anti-Infective Agents; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Hospitals; Hospitals, Public; Humans; Kidney Failure, Chronic; Linezolid; Malaysia; Oxazolidinones; Phenotype; Population Surveillance; Time Factors; Vancomycin Resistance | 2006 |
Enterococcus faecium as a cause of pulmonary abscesses in kidney transplant recipient.
Topics: Acetamides; Adult; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Lung Abscess; Male; Oxazolidinones | 2007 |
Linezolid therapy for infective endocarditis.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Endocarditis, Bacterial; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Infant; Linezolid; Male; Middle Aged; Oxazolidinones; Time Factors; Treatment Outcome | 2007 |
Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo.
Topics: Acetamides; Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Disease Models, Animal; DNA Primers; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Linezolid; Mice; Oxazolidinones; RNA, Bacterial; RNA, Ribosomal; RNA, Ribosomal, 16S; RNA, Ribosomal, 5S | 2007 |
In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
Topics: Animals; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; Disease Models, Animal; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Mice; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Oxazolidinones; Specific Pathogen-Free Organisms; Treatment Outcome | 2007 |
[Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Antineoplastic Agents; Drug Resistance, Bacterial; Enterococcus; Enterocolitis; Feces; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hemorrhage; Humans; Linezolid; Middle Aged; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chronic Disease; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Orthopedics; Osteomyelitis; Oxazolidinones; Prospective Studies; Prosthesis-Related Infections; Treatment Outcome | 2007 |
Colonization by a linezolid-resistant Enterococcus faecalis caused a urinary tract infection.
Topics: Acetamides; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Urinary Tract Infections | 2007 |
Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Health Care Costs; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin | 2007 |
Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child.
Topics: Acetamides; Anti-Infective Agents; Cerebral Ventricles; Encephalitis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Infant; Linezolid; Male; Oxazolidinones; Treatment Outcome; Vancomycin Resistance; Ventriculoperitoneal Shunt | 2007 |
Linezolid versus vancomycin for prosthetic joint infections: a cost analysis.
Topics: Acetamides; Administration, Oral; Algorithms; Anti-Bacterial Agents; Costs and Cost Analysis; Gram-Positive Bacterial Infections; Health Care Costs; Home Care Services; Humans; Infusions, Intravenous; Joint Prosthesis; Linezolid; Methicillin Resistance; Oxazolidinones; Prosthesis-Related Infections; Vancomycin | 2007 |
Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea.
Topics: Acetamides; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Ketolides; Korea; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Virginiamycin | 2007 |
LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Sentinel Surveillance; Staphylococcus aureus; Streptococcus; United States | 2007 |
Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection.
Topics: Acetamides; Child; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Ventriculoperitoneal Shunt | 2007 |
Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis.
Topics: Acetamides; Aged; Anti-Infective Agents; Aqueous Humor; Cornea; Endophthalmitis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Keratoplasty, Penetrating; Linezolid; Oxazolidinones; Postoperative Complications; Tissue Donors; Vancomycin Resistance; Vitreous Body | 2007 |
Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cost-Benefit Analysis; Female; Gram-Positive Bacterial Infections; Health Care Costs; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Spain; Teicoplanin | 2007 |
Vancomycin-resistant VanA phenotype Enterococcus faecalis: first case in Minas Gerais state and epidemiological considerations.
Topics: Acetamides; Adult; Anti-Infective Agents; Brazil; Cross Infection; Enterococcus faecalis; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Phenotype; Vancomycin Resistance | 2007 |
Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Global Health; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Population Surveillance | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
Phylogenetic analysis of vancomycin-resistant Enterococcus faecium genotypes associated with outbreaks or sporadic infections in Italy.
Topics: Acetamides; Animals; Anti-Infective Agents; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Italy; Linezolid; Oxazolidinones; Phylogeny; Sequence Analysis, DNA; Vancomycin Resistance; Virulence Factors | 2007 |
Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Cerebrospinal Fluid Shunts; Colony Count, Microbial; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Penicillin G; Propionibacterium acnes; Rifampin; Surgical Wound Infection; Titanium | 2007 |
Experience with linezolid therapy in children with osteoarticular infections.
Topics: Acetamides; Adolescent; Anti-Infective Agents; Arthritis, Infectious; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Infant; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Staphylococcus aureus; Treatment Outcome | 2007 |
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Parenteral Nutrition, Total; Peripheral Vascular Diseases; Retrospective Studies; Risk Factors; Transplants; Vancomycin Resistance | 2007 |
Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Korea; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Tigecycline; Vancomycin Resistance; Virginiamycin | 2007 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2008 |
[Our experience with linesolid usage in newborn children].
Topics: Acetamides; Anti-Bacterial Agents; Drug Administration Schedule; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2007 |
In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
Topics: Acetamides; Cross Infection; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance | 2008 |
Response to emerging infection leading to outbreak of linezolid-resistant enterococci.
Topics: Acetamides; Anti-Infective Agents; Case-Control Studies; Colony Count, Microbial; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Length of Stay; Linezolid; Microbial Sensitivity Tests; Multivariate Analysis; Oxazolidinones; Vancomycin Resistance | 2007 |
Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Incidence; Linezolid; Molecular Epidemiology; Mutation; Oxazolidinones; Vancomycin Resistance | 2008 |
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genes, Bacterial; Genes, rRNA; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Linezolid; Microbial Sensitivity Tests; Mucositis; Oxazolidinones; Pancreatitis, Acute Necrotizing; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2008 |
The in-vitro activity of linezolid (U-100766) and tentative breakpoints.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Colony Count, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Time Factors | 1998 |
Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin | 1999 |
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 1999 |
Battling drug resistance.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazoles; Oxazolidinones; Streptococcal Infections; Streptococcus pyogenes; Vancomycin Resistance; Virginiamycin | 1999 |
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Topics: Abdominal Abscess; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Male; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vancomycin | 1999 |
[Antibiosis. Therapeutic strategies in intensive care].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Critical Care; Drug Therapy; Gram-Positive Bacterial Infections; Humans; Linezolid; Needs Assessment; Oxazoles; Oxazolidinones | 1999 |
Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Oxazoles; Oxazolidinones; Postoperative Complications; Treatment Failure; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2000 |
Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Renal Dialysis; Spinal Diseases; Spine; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2000 |
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin | 2000 |
Linezolid: a new class of antibiotic.
Topics: Acetamides; Anti-Infective Agents; Drug Administration Schedule; Drug Costs; Drug Interactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Patient Selection; Practice Guidelines as Topic; Protein Synthesis Inhibitors | 2000 |
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Streptococcus; Treatment Outcome | 2000 |
Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Topics: Acetamides; Administration, Oral; Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faecium; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2001 |
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin | 2001 |
Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Carcinoma, Renal Cell; Cerebellar Neoplasms; Cerebrospinal Fluid; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Kidney Neoplasms; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance; Ventriculostomy | 2001 |
Linezolid for treatment of vancomycin-resistant enterococcal peritonitis.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin Resistance | 2001 |
Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hong Kong; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin Resistance | 2001 |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Taiwan | 2001 |
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands.
Topics: Acetamides; Anti-Bacterial Agents; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Netherlands; Oxazolidinones | 2001 |
Clinical experience with linezolid in the treatment of resistant gram-positive infections.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies | 2001 |
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil.
Topics: Acetamides; Anti-Bacterial Agents; Brazil; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance | 2001 |
In vitro activity of linezolid against Gram-positive cocci isolated in Poland.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones; Poland | 2001 |
Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Population Surveillance | 2002 |
In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patients.
Topics: Acetamides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory | 2002 |
Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Base Sequence; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Design and Construction; Humans; Linezolid; Liver Transplantation; Molecular Sequence Data; Mutation; Oxazolidinones; Vancomycin Resistance | 2002 |
Linezolid for the treatment of serious gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Canada; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Technology Assessment, Biomedical; United States | 2001 |
Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Utilization Review; Floxacillin; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Public; Humans; Infection Control; Infusions, Intravenous; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United Kingdom; Vancomycin | 2001 |
Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobial.
Topics: Acetamides; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cost-Benefit Analysis; Cross Infection; Drug Resistance, Bacterial; Formularies, Hospital as Topic; Gram-Positive Bacterial Infections; Humans; Infection Control; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; United States | 2001 |
Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Vancomycin Resistance | 2002 |
Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.
Topics: Acetamides; Anti-Bacterial Agents; Canada; Drug Approval; Drug Resistance; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2002 |